{"meta":{"query_hash":"2ee2419f4287","filters":{"venue":"Journal of Immunotherapy"},"cohort_total":55,"direct_labels_cover":0,"predictions_cover":55,"exported":55,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2ee2419f4287","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Immunotherapy"},"results":[{"id":"W1127933869","doi":"10.1097/cji.0000000000000089","title":"Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents","year":2015,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Clinical trial; Oncology; Drug development; Cancer; Chemotherapy; Disease; Immunotherapy; Drug; Internal medicine; Pharmacology","score_opus":0.23698800890256355,"score_gpt":0.4567935504305351,"score_spread":0.21980554152797155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1127933869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95859426,0.021520222,0.013830816,0.0021587855,0.0025134168,0.0011524676,0.00002049658,0.000014538028,0.00019499625],"genre_scores_gemma":[0.9819757,0.006272272,0.009297997,0.0018283552,0.00040279413,0.000019258092,0.0000022337865,0.000043390646,0.0001580497],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99642277,0.0005091588,0.0021535577,0.00015187301,0.00053047383,0.00023215343],"domain_scores_gemma":[0.9976811,0.00055255095,0.00089865486,0.00028074437,0.00045561258,0.0001313286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030157499,0.00018159692,0.00085477775,0.0002875505,0.000030117919,0.000024748395,0.0001449865,0.00016344656,0.00077986706],"category_scores_gemma":[0.00033219624,0.00013965383,0.00030197084,0.00025449943,0.0002485829,0.00013568152,0.000010441762,0.0004286355,0.000004202064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80622023,0.0036391285,0.028531572,0.000051289324,0.0030512311,0.0003006702,0.002938926,0.00041520572,0.03561335,0.00023377175,0.014065684,0.10493895],"study_design_scores_gemma":[0.7433259,0.034670796,0.1829468,0.001372572,0.00047320826,0.00094375684,0.0010678809,0.00061772077,0.007243648,0.00304973,0.023614004,0.0006740187],"about_ca_topic_score_codex":0.00012862482,"about_ca_topic_score_gemma":0.000009255297,"teacher_disagreement_score":0.15441523,"about_ca_system_score_codex":0.00023643592,"about_ca_system_score_gemma":0.0018343617,"threshold_uncertainty_score":0.8538997},"labels":[],"label_agreement":null},{"id":"W1964404276","doi":"10.1097/cji.0b013e318207ed14","title":"Identification of T-cell Epitopes by a Novel mRNA PCR-basedEpitope Chase Technique","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research","keywords":"Epitope; Messenger RNA; Molecular biology; Antigen; Polymerase chain reaction; Biology; CD8; T cell; Complementary DNA; Linear epitope; Virology; Computational biology; Gene; Immune system; Immunology; Genetics","score_opus":0.015970807546544178,"score_gpt":0.2423509917837237,"score_spread":0.22638018423717954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964404276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9099747,0.059871074,0.027813338,0.0001365975,0.001248613,0.00048010147,0.000069859256,0.000036920148,0.00036880054],"genre_scores_gemma":[0.9895112,0.006378381,0.0011354685,0.00018943782,0.000035485547,0.000023646895,0.000010315778,0.000053381656,0.0026627076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757403,0.00032050142,0.0014910792,0.00018544063,0.000106436935,0.0003224846],"domain_scores_gemma":[0.99717754,0.00015956812,0.0017714683,0.00049717794,0.0003713771,0.000022896844],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013432432,0.0002768255,0.00060798065,0.00036962872,0.00014163517,0.000017927116,0.0007187824,0.0003114289,0.000967163],"category_scores_gemma":[0.00006657594,0.00022719879,0.00039076435,0.0002476029,0.00030786658,0.0003247123,0.00002813602,0.0004779746,0.000050102946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003702955,0.0014004732,0.00019032731,0.000023846618,0.0004063889,0.0000039688243,0.0014336512,7.563009e-7,0.9789575,0.000082051425,0.001339947,0.01245815],"study_design_scores_gemma":[0.0038510172,0.0012228697,0.0014520694,0.000112436544,0.00003596779,0.0002759919,0.00026336353,5.874978e-7,0.95867145,0.00010944326,0.03378075,0.00022406269],"about_ca_topic_score_codex":0.0001126403,"about_ca_topic_score_gemma":7.598149e-7,"teacher_disagreement_score":0.07953648,"about_ca_system_score_codex":0.000055874923,"about_ca_system_score_gemma":0.00017973171,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W1970241155","doi":"10.1097/cji.0b013e318184908d","title":"Donor Regulatory T Cells Identified by FoxP3 Expression but Also by the Membranous CD4+CD127low/neg Phenotype Influence Graft-versus-tumor Effect After Donor Lymphocyte Infusion","year":2008,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"FOXP3; Medicine; IL-2 receptor; Malignancy; Immunology; Regulatory T cell; Interleukin-7 receptor; Population; Lymphocyte; Immunotherapy; T cell; Internal medicine; Immune system","score_opus":0.00569984326743634,"score_gpt":0.20977964559772558,"score_spread":0.20407980233028924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970241155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9268841,0.06865356,0.000092805814,0.00025004934,0.0034541837,0.000463,0.000042064323,0.000060167768,0.000100025194],"genre_scores_gemma":[0.9849823,0.008477513,0.000062677085,0.0011455306,0.00014240375,0.00004575887,0.000030538053,0.00008679086,0.005026468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961352,0.0010657748,0.0012848813,0.0004736483,0.00024686765,0.00079366425],"domain_scores_gemma":[0.9968146,0.000700029,0.0012370057,0.00088813825,0.0002724163,0.000087808185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092750596,0.00062230113,0.0009556911,0.00022918935,0.0007783061,0.0000704209,0.0011849919,0.0005437237,0.00097390165],"category_scores_gemma":[0.00009443096,0.000401511,0.0005583635,0.00026561538,0.00091722433,0.00052036025,0.00016613473,0.0010040279,0.00039946527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013703479,0.0003659178,0.0003963766,0.000023963363,0.0005596837,0.00007019422,0.00089872506,0.000019280895,0.94842625,0.0000027066274,0.031724073,0.003809383],"study_design_scores_gemma":[0.012502512,0.0014891112,0.0009428642,0.00015348656,0.00009576043,0.00067600777,0.00012686852,0.0000013570613,0.8755073,0.000017766703,0.108057685,0.0004292933],"about_ca_topic_score_codex":0.0002616013,"about_ca_topic_score_gemma":0.000008324775,"teacher_disagreement_score":0.07633361,"about_ca_system_score_codex":0.00022617361,"about_ca_system_score_gemma":0.00027700543,"threshold_uncertainty_score":0.9999393},"labels":[],"label_agreement":null},{"id":"W1973708763","doi":"10.1097/cji.0000000000000022","title":"Targeted siRNA Silencing of Indoleamine 2, 3-Dioxygenase in Antigen-presenting Cells Using Mannose-conjugated Liposomes","year":2014,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University; Cancer Care Ontario","funders":"Canadian Institutes of Health Research","keywords":"Indoleamine 2,3-dioxygenase; Immune system; Cancer research; Spleen; Small interfering RNA; Immunology; FOXP3; Antigen; Gene silencing; Antigen-presenting cell; T cell; Biology; Transfection; Cell culture","score_opus":0.012197924774438476,"score_gpt":0.2486350573814467,"score_spread":0.23643713260700822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973708763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678068,0.030214496,0.0005629596,0.000041312564,0.0010479884,0.00020619194,0.0000071736304,0.00002005103,0.00009299305],"genre_scores_gemma":[0.99617654,0.002470671,0.000772779,0.000140672,0.000080124766,0.0000017812952,0.0000065143186,0.00005861891,0.0002923168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99646723,0.00094706484,0.0016741671,0.0002209577,0.00013900969,0.0005515895],"domain_scores_gemma":[0.9972408,0.0004864631,0.0014998215,0.00042459962,0.00032213793,0.000026182135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016615292,0.00034434858,0.0009966749,0.0008661067,0.00015369063,0.00003167485,0.0006009542,0.00031954833,0.00037669652],"category_scores_gemma":[0.00018692866,0.0002954473,0.0003775975,0.000520187,0.00022746713,0.00037925265,0.000056007368,0.0006910293,0.000020343055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024493332,0.0003398052,0.0015827902,0.000031819545,0.00053062063,0.000019115841,0.0018459936,0.00038875482,0.9830243,0.000024711853,0.00006981072,0.0096929455],"study_design_scores_gemma":[0.0062086117,0.00064218795,0.013646719,0.0004365896,0.000015136773,0.0002457108,0.0005643532,0.00009463798,0.97390866,0.000067830355,0.0038812433,0.00028828954],"about_ca_topic_score_codex":0.0002156152,"about_ca_topic_score_gemma":0.0000050647523,"teacher_disagreement_score":0.028369687,"about_ca_system_score_codex":0.000087049346,"about_ca_system_score_gemma":0.00018363411,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W1973747829","doi":"10.1097/cji.0b013e3182941813","title":"Murine Responses to Recombinant MVA Versus ALVAC Vaccines Against Tumor-associated Antigens, gp100 and 5T4","year":2013,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University Health Network","funders":"","keywords":"Immunogenicity; Antigen; Immune system; Virology; Biology; Modified vaccinia Ankara; Vaccination; Immunology; Viral vector; Vector (molecular biology); Immunotherapy; Antibody; Recombinant DNA; Vaccinia","score_opus":0.012952479326827242,"score_gpt":0.25491623072430136,"score_spread":0.2419637513974741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973747829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95430857,0.039649915,0.0000432942,0.0022289036,0.003167731,0.0004227782,0.000009876089,0.00005050752,0.00011843323],"genre_scores_gemma":[0.97928697,0.013835428,0.0003052677,0.0014770987,0.00008307379,0.000022536018,0.000011206899,0.00008116451,0.0048972606],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970822,0.0007642275,0.0011131524,0.0002783006,0.00012221583,0.0006399299],"domain_scores_gemma":[0.99743897,0.00078350015,0.000765738,0.00044661507,0.0004979026,0.00006726424],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010389652,0.00042248756,0.0008911288,0.00055501866,0.00036473505,0.000112185175,0.00054493494,0.00025025313,0.0010423888],"category_scores_gemma":[0.0004956515,0.00033044623,0.00030044172,0.00040013503,0.0001258712,0.0004352732,0.0000813361,0.00058878504,0.00028499076],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014520385,0.0004006783,0.0031888,0.000008811572,0.0012750459,0.00002584163,0.0012337321,0.0000035422945,0.92463434,0.000023761411,0.009895632,0.04478945],"study_design_scores_gemma":[0.029728059,0.009242431,0.3760152,0.0006647184,0.00010513043,0.0009385123,0.0016305468,0.0000043938817,0.3063188,0.0002111055,0.27400425,0.001136884],"about_ca_topic_score_codex":0.00020500127,"about_ca_topic_score_gemma":0.000012865724,"teacher_disagreement_score":0.6183155,"about_ca_system_score_codex":0.00012864327,"about_ca_system_score_gemma":0.00018463598,"threshold_uncertainty_score":0.99991477},"labels":[],"label_agreement":null},{"id":"W1990951986","doi":"10.1097/cji.0000000000000055","title":"Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)","year":2014,"lang":"fr","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Amgen","keywords":"Renal cell carcinoma; Medicine; Adjuvant; Interleukin 2; Interferon; Cancer research; Oncology; Internal medicine; Cytokine; Immunology","score_opus":0.011849089476180793,"score_gpt":0.25664498185556045,"score_spread":0.24479589237937965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990951986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80498296,0.17869782,0.0016912086,0.0033256016,0.008320073,0.00051070884,0.000023134162,0.000018095261,0.0024303745],"genre_scores_gemma":[0.9579197,0.022909984,0.0012369581,0.0029426047,0.0024579512,0.000013799813,0.000008659211,0.00016380484,0.012346497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99397844,0.0007238646,0.0028678658,0.00047971797,0.00078932196,0.001160779],"domain_scores_gemma":[0.99666893,0.00036298367,0.00140004,0.00080601353,0.00041929056,0.00034276204],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032780615,0.00072699034,0.0017002672,0.0008336931,0.00013248135,0.00017302418,0.0009341149,0.00046806267,0.00307526],"category_scores_gemma":[0.000095260664,0.0006190083,0.0009300173,0.0006475369,0.00043568318,0.00062483613,0.00008612682,0.0017549649,0.00014014043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043527074,0.0016259057,0.003122084,0.0005390529,0.0007513358,0.00073734624,0.008535447,0.00032985516,0.45203143,0.000051555257,0.013798459,0.47495046],"study_design_scores_gemma":[0.108066946,0.030382583,0.0391698,0.016680053,0.0004271187,0.0044166776,0.0043245987,0.004453625,0.15989487,0.0002760373,0.6299869,0.00192081],"about_ca_topic_score_codex":0.0013108383,"about_ca_topic_score_gemma":0.00019964957,"teacher_disagreement_score":0.6161884,"about_ca_system_score_codex":0.002124885,"about_ca_system_score_gemma":0.0012206635,"threshold_uncertainty_score":0.9996261},"labels":[],"label_agreement":null},{"id":"W1991536229","doi":"10.1097/01.cji.0000210081.60178.b4","title":"Dendritic Cells Matured With TNF can be Further Activated In Vitro and After Subcutaneous Injection In Vivo Which Converts Their Tolerogenicity Into Immunogenicity","year":2006,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian MPS Society for Mucopolysaccharide and Related Diseases","funders":"","keywords":"Immunogenicity; In vivo; In vitro; Subcutaneous injection; Tumor necrosis factor alpha; Chemistry; Cell biology; Immunology; Medicine; Biology; Internal medicine; Biotechnology; Immune system; Biochemistry","score_opus":0.0038232249605540626,"score_gpt":0.19878301707523083,"score_spread":0.19495979211467676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991536229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754266,0.023173641,0.000049642473,0.00043485864,0.0004638532,0.00036697235,0.000024424728,0.00002460848,0.000035409448],"genre_scores_gemma":[0.9973284,0.0017222282,0.00012832817,0.00035783957,0.00003484108,0.000021640579,0.000009062301,0.00006598552,0.00033165654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972637,0.0007438278,0.0009986417,0.00031112702,0.00011608097,0.0005665665],"domain_scores_gemma":[0.99859643,0.00027111982,0.0005276796,0.000352038,0.00022813828,0.000024566756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059220806,0.00045464054,0.00082812033,0.0005903176,0.00013071344,0.000064811764,0.00031545592,0.0004668898,0.0002914318],"category_scores_gemma":[0.000018660648,0.0003478843,0.0001716172,0.0005542136,0.00026641283,0.00030597145,0.00003611774,0.0009839627,0.0000041701423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0450242,0.0004741025,0.002193214,0.000018071645,0.00039074753,0.000121228135,0.003144835,0.000052296655,0.94482714,0.000004140267,0.00004296726,0.0037070804],"study_design_scores_gemma":[0.007779027,0.0011935789,0.018785242,0.00021918808,0.000028379472,0.00292213,0.0008967666,0.0000058273145,0.96565163,0.00011226217,0.0020000672,0.00040592198],"about_ca_topic_score_codex":0.0025451565,"about_ca_topic_score_gemma":0.0018330439,"teacher_disagreement_score":0.037245173,"about_ca_system_score_codex":0.00030534502,"about_ca_system_score_gemma":0.00023905987,"threshold_uncertainty_score":0.9998973},"labels":[],"label_agreement":null},{"id":"W1995183264","doi":"10.1097/01.cji.0000175693.08608.a8","title":"LF 15-0195 Generates Synergistic Tolerance by Promoting Formation of CD4+CD25+CTLA4+ T Cells","year":2005,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Chemistry; Cell biology; Biology","score_opus":0.007262054139875491,"score_gpt":0.22939263831298465,"score_spread":0.22213058417310916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995183264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8807104,0.11348056,0.0039089983,0.00051173684,0.0009433682,0.00023173909,0.000025807694,0.000026914793,0.00016044467],"genre_scores_gemma":[0.98837817,0.007927197,0.0008173762,0.00043925384,0.0001418968,0.0000075898574,0.000020350742,0.000049370614,0.002218813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971382,0.00057743146,0.0015492981,0.00016975611,0.0001317125,0.0004336246],"domain_scores_gemma":[0.99737823,0.000313353,0.0015754207,0.00034657278,0.00036077446,0.000025676685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012365143,0.0003113596,0.0006988458,0.0002589251,0.00021716853,0.00004319755,0.0005345051,0.00027237902,0.00077303976],"category_scores_gemma":[0.000081125516,0.00025337946,0.000344182,0.00023149949,0.00020658551,0.0006457633,0.000026156316,0.0005226167,0.0000923157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015695055,0.00035493818,0.00004328932,0.000030583426,0.00031389063,0.0000025710733,0.0019967826,0.00017126565,0.9121324,0.00003146829,0.005872092,0.07748123],"study_design_scores_gemma":[0.0031943966,0.0007739675,0.0001697527,0.00023639934,0.00003204417,0.00021555617,0.0001928806,0.0000859869,0.87056893,0.000029985355,0.124269895,0.00023021302],"about_ca_topic_score_codex":0.000025710217,"about_ca_topic_score_gemma":0.000002211721,"teacher_disagreement_score":0.1183978,"about_ca_system_score_codex":0.00010523046,"about_ca_system_score_gemma":0.00013589048,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W2000145027","doi":"10.1097/cji.0b013e31823735d6","title":"Ipilimumab in Treatment-naive and Previously Treated Patients with Metastatic Melanoma","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"National Comprehensive Cancer Network; Bristol-Myers Squibb","keywords":"Ipilimumab; Medicine; Internal medicine; Placebo; Clinical endpoint; Diarrhea; Gastroenterology; Clinical trial; Oncology; Surgery; Cancer; Immunotherapy; Pathology","score_opus":0.020619749534033782,"score_gpt":0.2517715644603501,"score_spread":0.2311518149263163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000145027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923521,0.0066852444,0.000019231533,0.00007924103,0.000060423616,0.00042048778,0.0000038548196,0.000007834603,0.00037155868],"genre_scores_gemma":[0.9936047,0.0045098416,0.0014254373,0.00019915237,0.000024335835,0.000008954689,0.000003558666,0.00003028629,0.00019369299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893516,0.000071125825,0.00048446693,0.00012268842,0.00019037118,0.00019619838],"domain_scores_gemma":[0.9992436,0.000041137595,0.0003465535,0.00016625247,0.00013126554,0.00007119558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018309685,0.00018950457,0.00048750232,0.00024656113,0.00003154782,0.000013905101,0.000068352325,0.000043897442,0.00020879092],"category_scores_gemma":[0.0000074524905,0.0001103727,0.00011728394,0.00019439308,0.000087857545,0.00016139507,0.0000039461333,0.00011323341,0.0000017887498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056288473,0.0020357857,0.7480576,0.000032129665,0.002203001,0.00024319599,0.007409944,3.4126487e-7,0.005783737,0.0000069997,0.00008224128,0.17785656],"study_design_scores_gemma":[0.050557207,0.01840611,0.9206859,0.00044120848,0.00021778005,0.00036203503,0.0003560954,0.0000035012017,0.0068061543,0.000040681545,0.0019419043,0.00018143893],"about_ca_topic_score_codex":0.00025046882,"about_ca_topic_score_gemma":0.000038204078,"teacher_disagreement_score":0.17767513,"about_ca_system_score_codex":0.0002026722,"about_ca_system_score_gemma":0.00012343058,"threshold_uncertainty_score":0.4500868},"labels":[],"label_agreement":null},{"id":"W2004345869","doi":"10.1097/01.cji.0000210386.55951.c2","title":"IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells","year":2006,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":441,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute","keywords":"CD8; Cytokine; Immunology; Immunotherapy; In vivo; Interleukin 2; Human immunodeficiency virus (HIV); Medicine; T lymphocyte; Cancer research; Pharmacology; Biology; Immune system; Biotechnology","score_opus":0.00880907357123193,"score_gpt":0.2424195119768947,"score_spread":0.23361043840566278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004345869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938681,0.0018184179,0.0020190733,0.000218966,0.0014785272,0.00022449021,0.000012747208,0.000008585843,0.0003510713],"genre_scores_gemma":[0.99271697,0.00024971698,0.00064440677,0.00027203964,0.000055097044,0.000003364288,0.000009995019,0.00002116795,0.00602722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984571,0.00019275316,0.0009232586,0.00015441651,0.000095463896,0.00017704634],"domain_scores_gemma":[0.9985111,0.00012375144,0.00073585025,0.0002215623,0.00036693033,0.000040841653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040010174,0.00018086389,0.00043021268,0.00035124487,0.0000896987,0.00001280881,0.00014126742,0.00018434267,0.00060204894],"category_scores_gemma":[0.000034499535,0.00015706595,0.00018254315,0.00015044774,0.00011098011,0.00023698989,0.000020242232,0.0002603755,0.000041834486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030132066,0.00026343224,0.0002874716,0.000014838777,0.00012111797,0.0000028168731,0.0008203111,0.000074848955,0.98630583,0.00016231132,0.006775716,0.0021581233],"study_design_scores_gemma":[0.0017645634,0.002553185,0.008232785,0.00017510339,0.000034756293,0.0000647972,0.00044885487,0.0000014601007,0.9639602,0.00006163418,0.022562832,0.00013988565],"about_ca_topic_score_codex":0.00012876917,"about_ca_topic_score_gemma":0.000014329626,"teacher_disagreement_score":0.022345662,"about_ca_system_score_codex":0.00006760958,"about_ca_system_score_gemma":0.00013821806,"threshold_uncertainty_score":0.6592013},"labels":[],"label_agreement":null},{"id":"W2005889192","doi":"10.1097/cji.0b013e3181cd872d","title":"IL-7 Enhances Survival of Human CD56bright NK Cells","year":2010,"lang":"fr","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Stimulation; Cell biology; Lymphokine-activated killer cell; Interleukin 21; Interleukin 12; Cytokine; Interleukin 15; Janus kinase 3; Biology; Immunology; Cell; Cancer research; Interleukin; Immune system; T cell; In vitro; Cytotoxic T cell; Neuroscience","score_opus":0.01038586555752329,"score_gpt":0.26277201569734426,"score_spread":0.25238615013982096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005889192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8729109,0.034127526,0.0003980853,0.0009502953,0.08744686,0.0001322597,0.000011699254,0.000011954901,0.0040103947],"genre_scores_gemma":[0.85695904,0.015843753,0.0002842021,0.0003042336,0.0009976048,0.0000019914366,0.000012946229,0.00005616601,0.12554008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974827,0.0004426141,0.0013994696,0.0001750792,0.00012577404,0.0003743301],"domain_scores_gemma":[0.99698555,0.00023756539,0.0017398627,0.0003719294,0.00062543276,0.000039659837],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010406309,0.00029579774,0.0007468095,0.00030423337,0.00022105148,0.000038280585,0.0004780986,0.0005734867,0.024581896],"category_scores_gemma":[0.00004328606,0.0002538709,0.00059866934,0.00017062211,0.00056409993,0.00044115068,0.000029548895,0.0017115893,0.00034943206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010708167,0.00073515234,0.00024637085,0.00005160064,0.0008976212,0.000009322109,0.0009581106,0.0000027515953,0.96172273,0.0012934142,0.019421063,0.01359102],"study_design_scores_gemma":[0.0017548443,0.0012305499,0.0008637436,0.00018051018,0.000043759053,0.00024149174,0.0002904001,7.912721e-7,0.5816533,0.00013377232,0.41346171,0.00014510646],"about_ca_topic_score_codex":0.00017607225,"about_ca_topic_score_gemma":0.000044020424,"teacher_disagreement_score":0.39404067,"about_ca_system_score_codex":0.000057987756,"about_ca_system_score_gemma":0.00017550075,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W2008591960","doi":"10.1097/00002371-200501000-00004","title":"Effect of Serum and Antioxidants on the Immunogenicity of Protein Kinase C-Activated Chronic Lymphocytic Leukemia Cells","year":2004,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Immunogenicity; Chronic lymphocytic leukemia; Immune system; Protein kinase C; Immunology; Chemistry; Cancer research; Cell biology; Leukemia; Biology; Signal transduction","score_opus":0.008655550279923095,"score_gpt":0.2739041142319836,"score_spread":0.2652485639520605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008591960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992609,0.006124452,0.000034964738,0.0001457787,0.00010236886,0.0008768651,0.000008177994,0.000009738643,0.000088637],"genre_scores_gemma":[0.99746925,0.00212073,0.00009965172,0.00006976502,0.000089688496,0.000007762213,5.5579443e-7,0.000044938988,0.00009766825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975549,0.00028942153,0.0008441596,0.00017183421,0.0007925024,0.00034720675],"domain_scores_gemma":[0.997862,0.00042556095,0.00079021987,0.00054520275,0.00027895826,0.00009806042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016040287,0.00025864292,0.000808554,0.00023602096,0.00007476556,0.000018301362,0.0003264384,0.00014814458,0.00012683248],"category_scores_gemma":[0.00019481787,0.00014966963,0.0003154392,0.00038870468,0.0003766231,0.00011485088,0.000046417405,0.0004534348,0.000006163677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007866846,0.00009840275,0.000041863666,0.00040732825,0.00057006587,0.0001061097,0.0002759424,0.0005603049,0.978154,0.00004373286,0.00001684183,0.0118585685],"study_design_scores_gemma":[0.044843595,0.009202649,0.0011155213,0.00224284,0.00007025248,0.0005162996,0.00004112123,0.0002699234,0.94142133,0.000060610055,0.00010617975,0.000109687695],"about_ca_topic_score_codex":0.00049807585,"about_ca_topic_score_gemma":0.0000030199494,"teacher_disagreement_score":0.036976747,"about_ca_system_score_codex":0.024147388,"about_ca_system_score_gemma":0.013932991,"threshold_uncertainty_score":0.9916571},"labels":[],"label_agreement":null},{"id":"W2015821984","doi":"10.1097/00002371-200007000-00009","title":"Induction of Tumor-Specific Immunity in Mice by Immunization With Reconstituted Tumor Membrane Liposomes Containing Recombinant B7-2 (CD86)","year":2000,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sept Iles","funders":"National Cancer Institute","keywords":"Immunogenicity; CD86; Immunization; Recombinant DNA; Liposome; Fibrosarcoma; Cancer research; Immunology; Biology; Immune system; Chemistry; Medicine; T cell; Gene; Biochemistry; Pathology","score_opus":0.010235376897674696,"score_gpt":0.22401098642193393,"score_spread":0.21377560952425922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015821984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94365835,0.054511674,0.00012546497,0.00020908656,0.00080370286,0.00033179726,0.000013566189,0.000028035558,0.00031830816],"genre_scores_gemma":[0.9790425,0.01932528,0.00031920927,0.00016436788,0.000029142591,0.000011202284,0.000044534387,0.000059102404,0.0010047086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965241,0.0010175981,0.0016244905,0.00023732906,0.00013622404,0.0004602635],"domain_scores_gemma":[0.9975597,0.00034175985,0.0012953074,0.00042537943,0.00035259893,0.00002522763],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013231991,0.0003882444,0.0010009162,0.0005750724,0.00024930382,0.000042176565,0.00059232285,0.0002234287,0.0023652855],"category_scores_gemma":[0.00005643904,0.00031262974,0.00022549444,0.0007034935,0.00046923905,0.0007103737,0.00002006404,0.0010207696,0.000036600562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020721747,0.00073832466,0.000982906,0.000016886526,0.00055079645,0.000023051605,0.0018274521,0.00006343335,0.909166,0.000042596934,0.0003394606,0.06552738],"study_design_scores_gemma":[0.014139365,0.0036377576,0.009100792,0.0010399256,0.000042615287,0.0025497177,0.002059009,0.000003118235,0.90531385,0.000055133776,0.061576944,0.00048175294],"about_ca_topic_score_codex":0.00047958558,"about_ca_topic_score_gemma":0.000014861061,"teacher_disagreement_score":0.065045625,"about_ca_system_score_codex":0.00018016249,"about_ca_system_score_gemma":0.00028445586,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W2020793885","doi":"10.1097/00002371-200201000-00008","title":"CD20-Directed Serotherapy in Patients With Multiple Myeloma: Biologic Considerations and Therapeutic Applications","year":2002,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"CD20; Rituximab; Medicine; Multiple myeloma; Lymphoma; Immunology; Bone marrow; Chronic lymphocytic leukemia; Monoclonal; Chemoimmunotherapy; Internal medicine; Leukemia; Monoclonal antibody; Antibody","score_opus":0.024551432524570784,"score_gpt":0.2738442964361995,"score_spread":0.24929286391162872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020793885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170554,0.0061767832,0.00020189784,0.00084943656,0.000023169612,0.00087768934,0.0000092884275,0.00002488546,0.00013130864],"genre_scores_gemma":[0.99426293,0.0016757227,0.003410438,0.00044264505,0.00003804143,0.00004909491,0.0000058743135,0.000023735034,0.000091528986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989107,0.00009257638,0.00038120447,0.00014325038,0.0002524418,0.00021980079],"domain_scores_gemma":[0.99903107,0.00020611243,0.00019294911,0.00019476205,0.00026901095,0.000106084786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001340734,0.00015626814,0.00034352829,0.00026731082,0.00010014284,0.000031841144,0.000060295297,0.000069535105,0.00033481413],"category_scores_gemma":[0.000034750432,0.000098507786,0.000063539024,0.00023618511,0.000105496096,0.00009299508,0.0000061331925,0.00023315393,0.000008855724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013418746,0.0014497298,0.91674244,0.0000118034495,0.00045857875,0.00003337414,0.0003786784,0.000006830186,0.0046427264,0.000031270924,0.00009158876,0.07481111],"study_design_scores_gemma":[0.0199715,0.0018564394,0.974934,0.00007642495,0.000023216697,0.0001054301,0.000044160144,0.00026287657,0.0005688002,0.00016250994,0.0018820029,0.00011268697],"about_ca_topic_score_codex":0.000016334609,"about_ca_topic_score_gemma":0.000017609202,"teacher_disagreement_score":0.07469842,"about_ca_system_score_codex":0.00008430926,"about_ca_system_score_gemma":0.000048146456,"threshold_uncertainty_score":0.4017031},"labels":[],"label_agreement":null},{"id":"W2021274125","doi":"10.1097/cji.0b013e3181c1f1e9","title":"A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses","year":2010,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Immunovaccine (Canada)","funders":"","keywords":"Adjuvant; Ovarian cancer; Immune system; Medicine; Peptide vaccine; Immunology; Lymph node; Cancer vaccine; Epitope; CD8; Antigen; FOXP3; Cancer; Immunotherapy; Internal medicine","score_opus":0.026861168625879853,"score_gpt":0.2738996614744544,"score_spread":0.24703849284857454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021274125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96182925,0.02917179,0.00017281095,0.0018953637,0.006292457,0.0003497805,0.00007277523,0.00006558688,0.00015017066],"genre_scores_gemma":[0.97280246,0.012267163,0.0011381807,0.000854586,0.00047602484,0.000012422288,0.000021907194,0.00013554978,0.0122917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973447,0.00024776784,0.0011103884,0.00035534316,0.00020280348,0.00073900266],"domain_scores_gemma":[0.9968208,0.0005846057,0.0010830532,0.0007764374,0.00067354215,0.000061550316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012962936,0.0005543833,0.00094302057,0.00057399034,0.00042549687,0.00012413063,0.0009730702,0.0005756422,0.005606119],"category_scores_gemma":[0.00014905057,0.00041960712,0.00044658754,0.0004620372,0.00027178825,0.00061196624,0.00006464133,0.0017094986,0.00021833903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041299663,0.00053178583,0.0012488675,0.000011451059,0.001167887,0.000029166762,0.0009797473,0.0000024516423,0.9060568,0.00022817144,0.002517838,0.04592617],"study_design_scores_gemma":[0.00871098,0.001395405,0.0642354,0.00020501572,0.00006234007,0.006536566,0.0003003496,0.0000015008158,0.6115095,0.00007222746,0.3064779,0.0004928029],"about_ca_topic_score_codex":0.00033483858,"about_ca_topic_score_gemma":0.000050101695,"teacher_disagreement_score":0.30396006,"about_ca_system_score_codex":0.00015260011,"about_ca_system_score_gemma":0.0006521578,"threshold_uncertainty_score":0.9998256},"labels":[],"label_agreement":null},{"id":"W2041021823","doi":"10.1097/cji.0b013e318207ecdf","title":"The Human Cathelicidin, LL-37, Induces Granzyme-mediated Apoptosis in Regulatory T Cells","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Granzyme; Granzyme A; Granzyme B; Apoptosis; Cytotoxic T cell; Cathelicidin; IL-2 receptor; FOXP3; Programmed cell death; Biology; DNA fragmentation; Molecular biology; Caspase; Perforin; Immune system; Cell biology; Chemistry; T cell; Immunology; CD8; Innate immune system; Biochemistry; In vitro","score_opus":0.018572491192891914,"score_gpt":0.23052064366653102,"score_spread":0.2119481524736391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041021823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990428,0.007797087,0.000010888366,0.00019771383,0.0008617845,0.00010549626,0.000005774996,0.000013595048,0.000579684],"genre_scores_gemma":[0.9947729,0.0036035704,0.000057358608,0.00030886312,0.00006284743,0.000003063428,0.000002746764,0.00002553051,0.0011631196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862814,0.00022475171,0.0006439739,0.000117429634,0.0000553956,0.00033031506],"domain_scores_gemma":[0.9989046,0.00015994991,0.0005730447,0.00023952886,0.000105090934,0.00001777549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006871543,0.0001856582,0.0003609614,0.00014155683,0.00030550172,0.000028450022,0.00047730474,0.00020164275,0.00035028352],"category_scores_gemma":[0.000018010613,0.00011819048,0.00021253501,0.00013417446,0.00035758648,0.00019213365,0.000029900286,0.0005498646,0.000056812816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028635687,0.0001861701,0.00067691214,0.0000032856242,0.00022154285,0.0000039389374,0.0024522878,9.75943e-7,0.989023,0.0002924446,0.0036284442,0.003224671],"study_design_scores_gemma":[0.0016066667,0.00037251328,0.010365959,0.00008828772,0.000016437156,0.00005597012,0.0012030479,9.388429e-8,0.9732342,0.00042621628,0.012465131,0.00016549385],"about_ca_topic_score_codex":0.00027220283,"about_ca_topic_score_gemma":0.000031214688,"teacher_disagreement_score":0.015788786,"about_ca_system_score_codex":0.000050120096,"about_ca_system_score_gemma":0.00006963531,"threshold_uncertainty_score":0.4819668},"labels":[],"label_agreement":null},{"id":"W2042901152","doi":"10.1097/cji.0b013e318197b2a0","title":"Semiquantitation of Mouse Dendritic Cell Migration In Vivo Using Cellular MRI","year":2009,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; In vivo; Magnetic resonance imaging; Cancer research; Dendritic cell; Immune system; Adjuvant; Breast cancer; Pathology; Cancer; Immunology; Internal medicine; Biology; Radiology","score_opus":0.012507857667938108,"score_gpt":0.2560128178451338,"score_spread":0.2435049601771957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042901152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95598197,0.039926305,0.003309296,0.00016121328,0.000398828,0.00014037809,0.000004488085,0.000008416889,0.00006913282],"genre_scores_gemma":[0.9930058,0.0048068403,0.0011652206,0.00016012942,0.00002392104,8.5447584e-7,0.0000040595037,0.000019636678,0.0008135151],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818087,0.00039684857,0.000980222,0.00011350623,0.0000811914,0.0002473758],"domain_scores_gemma":[0.99866986,0.00014654767,0.0007525958,0.00021778105,0.00020230238,0.000010918495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066178193,0.00018068621,0.00046162706,0.000502371,0.000073237265,0.000017891307,0.00025598623,0.00021212726,0.00027956584],"category_scores_gemma":[0.000035833247,0.00016061937,0.00022690545,0.00025813884,0.00008552463,0.0003317272,0.0000065077675,0.00032714964,0.000009267955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002023852,0.00043325426,0.00055668224,0.000012192012,0.0000885726,0.0000085377205,0.0014174402,0.00031504518,0.99240005,0.00007345065,0.0001831411,0.0024877891],"study_design_scores_gemma":[0.0035207646,0.0011403176,0.001502381,0.0001686782,0.00002137523,0.000111164474,0.00046823826,0.0000386739,0.9890394,0.00013151579,0.0037022382,0.00015524538],"about_ca_topic_score_codex":0.00007088234,"about_ca_topic_score_gemma":0.0000054812167,"teacher_disagreement_score":0.037023883,"about_ca_system_score_codex":0.00008530392,"about_ca_system_score_gemma":0.0001392413,"threshold_uncertainty_score":0.6549868},"labels":[],"label_agreement":null},{"id":"W2054621145","doi":"10.1097/01.cji.0000191021.90544.75","title":"The Role of the Ovarian Tumor Marker CA125 (MUC16) in the Suppression of Human Immune Responses","year":2005,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Innate immune system; Immune system; Immunity; Ovarian cancer; Immunology; Tumor immunology; Medicine; Biology; Immunotherapy; Cancer; Internal medicine","score_opus":0.013656639850133406,"score_gpt":0.3192505343208218,"score_spread":0.3055938944706884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054621145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96777827,0.018639922,0.0000016768205,0.011470772,0.0000988871,0.00023239922,0.0000060970274,0.000001667822,0.0017703268],"genre_scores_gemma":[0.9950119,0.0022110108,0.00011637638,0.0003780188,0.000201795,0.0000036899346,6.591662e-7,0.0000149687785,0.0020615663],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99756646,0.0005553624,0.0008213867,0.000074577,0.00075437676,0.00022784204],"domain_scores_gemma":[0.99817747,0.00061095296,0.00052667403,0.0004303154,0.00022052429,0.000034041605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002227176,0.00012422635,0.00034642327,0.000116949,0.000202468,0.000020978378,0.00067386805,0.000050525952,0.00023703465],"category_scores_gemma":[0.00013819266,0.000047569567,0.00033394527,0.00023901844,0.00028931344,0.000074478536,0.000054844997,0.0005700256,0.000002177657],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009517289,0.0004025171,0.026647383,0.000023403087,0.0001958413,0.000021348518,0.002107686,0.000006291174,0.9272982,0.0006273066,0.0011643507,0.0319884],"study_design_scores_gemma":[0.0022936773,0.00077415165,0.6667266,0.00048960256,0.000025234684,0.00043540358,0.0011033237,0.000040982,0.17475507,0.0006886775,0.15259555,0.000071764305],"about_ca_topic_score_codex":0.00025442676,"about_ca_topic_score_gemma":0.000037328165,"teacher_disagreement_score":0.7525431,"about_ca_system_score_codex":0.000043361244,"about_ca_system_score_gemma":0.00019836366,"threshold_uncertainty_score":0.2595363},"labels":[],"label_agreement":null},{"id":"W2056969658","doi":"10.1097/cji.0b013e31802cf3e3","title":"“Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells","year":2007,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immune system; PLGA; Antigen; Adjuvant; Dendritic cell; Proinflammatory cytokine; Antigen-presenting cell; T cell; Chemistry; Immunology; Biology; In vitro; Inflammation; Biochemistry","score_opus":0.011860697973561313,"score_gpt":0.2622933895295807,"score_spread":0.2504326915560194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056969658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522565,0.036205616,0.008258962,0.0004490018,0.002350822,0.00038831885,0.000018240718,0.000030433946,0.00004208143],"genre_scores_gemma":[0.991538,0.0017087939,0.003188202,0.0018571962,0.00017113572,0.000010274361,0.000005715927,0.00006835208,0.0014523539],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997825,0.00016999121,0.0010817574,0.00019172441,0.00008838566,0.00064310886],"domain_scores_gemma":[0.99799055,0.0007367903,0.00046744692,0.0003297077,0.000427039,0.000048494327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018700609,0.0002719385,0.0005569933,0.00044629772,0.0002590182,0.000041117386,0.0005205861,0.00021525784,0.00036059038],"category_scores_gemma":[0.00011302486,0.00022600607,0.00041167444,0.00025594764,0.00006760762,0.00021315612,0.000030404835,0.0003019566,0.00012418815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010444301,0.0002653265,0.0001380715,0.000010763487,0.00045867055,0.000018494015,0.0009744501,0.000016633805,0.9197503,0.00009085405,0.0028943326,0.06493786],"study_design_scores_gemma":[0.004262872,0.0016900041,0.0022863762,0.0001034687,0.000036905967,0.00039854666,0.00036521206,4.9085355e-7,0.7654813,0.000084924526,0.22507502,0.00021489242],"about_ca_topic_score_codex":0.000014921662,"about_ca_topic_score_gemma":0.0000070320443,"teacher_disagreement_score":0.2221807,"about_ca_system_score_codex":0.00010514339,"about_ca_system_score_gemma":0.00013411712,"threshold_uncertainty_score":0.92162603},"labels":[],"label_agreement":null},{"id":"W2059063810","doi":"10.1097/cji.0b013e31820d2a21","title":"Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Institutes of Health; Johns Hopkins University","keywords":"Lymphokine-activated killer cell; Interleukin 12; Cytotoxicity; NK-92; NKG2D; Janus kinase 3; Interleukin 21; Natural killer cell; Biology; Cytotoxic T cell; Immunotherapy; Tumor necrosis factor alpha; Immunology; Cytolysis; Cell biology; Cancer research; Chemistry; Antigen; Immune system; In vitro; Biochemistry; CD8","score_opus":0.01593651748391285,"score_gpt":0.23729041762105,"score_spread":0.22135390013713713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059063810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799624,0.005512256,0.00017777727,0.00010018068,0.012798628,0.0002035839,8.949779e-7,0.00003136471,0.0012129131],"genre_scores_gemma":[0.99109906,0.00074904045,0.00018086933,0.00051027944,0.00010117973,0.000005984716,0.000007513449,0.000042454485,0.007303624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977413,0.00048905204,0.0010638672,0.00020315283,0.00009747217,0.00040517113],"domain_scores_gemma":[0.9981542,0.0002458629,0.0010534063,0.00021962904,0.00030051975,0.000026387213],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008024877,0.00028991536,0.000548641,0.0005578673,0.00013861536,0.00002976024,0.00031760603,0.00029731434,0.004748911],"category_scores_gemma":[0.000074325966,0.0002333341,0.00030654343,0.00027528428,0.00011186953,0.00070492167,0.000033507993,0.0012275036,0.00028366002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035266,0.0003642207,0.00018952224,0.00000767878,0.00035618816,0.000019735862,0.0029473852,0.000020580736,0.97271,0.000006430083,0.0076107676,0.012240899],"study_design_scores_gemma":[0.0039761723,0.0005990871,0.0026658694,0.00025080395,0.000012072283,0.00018536985,0.0009751454,0.000004943901,0.94636935,0.00006445981,0.04464574,0.00025097214],"about_ca_topic_score_codex":0.000080617836,"about_ca_topic_score_gemma":0.000003048572,"teacher_disagreement_score":0.037034974,"about_ca_system_score_codex":0.00017439685,"about_ca_system_score_gemma":0.00010328557,"threshold_uncertainty_score":0.99616086},"labels":[],"label_agreement":null},{"id":"W2073651499","doi":"10.1097/cji.0b013e3181a6981c","title":"Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin","year":2009,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Immunotoxin; Epitope; Epithelial cell adhesion molecule; In vitro; Linker; Chemistry; Molecular biology; Fusion protein; Furin; Moiety; Recombinant DNA; In vivo; Biology; Cell; Biochemistry; Antigen; Gene; Cytotoxicity; Stereochemistry; Immunology; Genetics","score_opus":0.010394736040329706,"score_gpt":0.20453073554271795,"score_spread":0.19413599950238825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073651499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245787,0.004521916,0.0018651541,0.000120867815,0.00069240754,0.00025866638,0.000048883172,0.00001692485,0.000017310822],"genre_scores_gemma":[0.9978759,0.0013671562,0.000489536,0.00014220962,0.000043463722,0.0000022941897,0.000019057854,0.00002369348,0.000036665137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980921,0.000290197,0.0010438088,0.00018380684,0.00008480139,0.00030525797],"domain_scores_gemma":[0.9982315,0.00010652417,0.0011298073,0.00035254203,0.00015120802,0.000028448765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078839355,0.00025763022,0.000708822,0.00017694393,0.00013864717,0.000029590994,0.00049795816,0.0002999408,0.00013733542],"category_scores_gemma":[0.00007653607,0.0001717106,0.0002101476,0.00019687877,0.00015259758,0.00022872316,0.000037551235,0.0004733482,0.000002143225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006158401,0.00028534225,0.00070209644,0.0000109067005,0.0001616831,0.000007787365,0.0016255109,0.000017102366,0.99130064,0.0006425083,0.0000067853152,0.004623791],"study_design_scores_gemma":[0.003337269,0.0025763912,0.10207201,0.0002493077,0.00002899197,0.0004170927,0.00035299672,0.000047381,0.88922924,0.00010013826,0.0013805564,0.00020860652],"about_ca_topic_score_codex":0.000012991568,"about_ca_topic_score_gemma":4.830289e-7,"teacher_disagreement_score":0.10207139,"about_ca_system_score_codex":0.000027274164,"about_ca_system_score_gemma":0.00011082981,"threshold_uncertainty_score":0.7002155},"labels":[],"label_agreement":null},{"id":"W2077633929","doi":"10.1097/cji.0b013e318243f213","title":"Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"Ovarian cancer; Cytotoxic T cell; Immunotherapy; Medicine; Cancer immunotherapy; Immunology; Lymphocyte; Cancer; Cancer research; Immune system; Internal medicine; Biology","score_opus":0.03650980964972917,"score_gpt":0.3572020405419712,"score_spread":0.320692230892242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077633929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8895075,0.09518518,0.0056442535,0.0037539403,0.0025554982,0.0015683138,0.00002628658,0.0000558521,0.0017031918],"genre_scores_gemma":[0.87455446,0.07098187,0.014011152,0.0066163526,0.0082976455,0.00023216537,0.000012712829,0.00045485934,0.0248388],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974337,0.000114904135,0.00084256363,0.00016237109,0.00069408125,0.00075236754],"domain_scores_gemma":[0.9979409,0.00022652453,0.0005202669,0.00048716753,0.0005455307,0.0002796023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001638997,0.0002915753,0.0007607908,0.00040073888,0.00014001934,0.00005832296,0.00034719097,0.00018865385,0.0069776066],"category_scores_gemma":[0.000054143904,0.00022286203,0.00070990133,0.00033833706,0.00011105963,0.00037563493,0.000017510887,0.00045076493,0.000023573819],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008910521,0.00042374356,0.0043891235,0.000036403013,0.0010123887,0.00001021262,0.0010887285,0.0000054347074,0.74057484,0.00008922252,0.0020528752,0.24140653],"study_design_scores_gemma":[0.023431906,0.0020187586,0.02197187,0.0003019636,0.00008734102,0.0010441612,0.00020992305,0.0000458213,0.2309029,0.00020095454,0.7194452,0.00033917604],"about_ca_topic_score_codex":0.000073788455,"about_ca_topic_score_gemma":0.0000028063262,"teacher_disagreement_score":0.7173924,"about_ca_system_score_codex":0.0007508512,"about_ca_system_score_gemma":0.0006520085,"threshold_uncertainty_score":0.99393016},"labels":[],"label_agreement":null},{"id":"W2078126933","doi":"10.1097/cji.0000000000000031","title":"T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells","year":2014,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Division of Chemistry; Laboratorio de Inmunología y Virología, Universidad Autónoma de Nuevo León; Northeast Agricultural University; Institut National de la Santé et de la Recherche Médicale","keywords":"CTL*; Cytotoxic T cell; Human leukocyte antigen; Medicine; Immunology; Virus; Lymphoma; Toxicity; Population; Immunotherapy; Virology; Antigen; Internal medicine; Immune system; Biology; CD8; In vitro","score_opus":0.018611759531367258,"score_gpt":0.26409209350927226,"score_spread":0.245480333977905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078126933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760213,0.020106066,0.0016084712,0.00025904688,0.00041567127,0.00015910034,0.0000019081547,0.000009328449,0.0014191438],"genre_scores_gemma":[0.97987884,0.017245134,0.0015449646,0.0008421338,0.00024900344,9.5072727e-7,7.198249e-7,0.00004483956,0.00019342816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985213,0.00009191645,0.000645214,0.00011001628,0.00040231415,0.00022922773],"domain_scores_gemma":[0.9985667,0.000059665534,0.00079314125,0.00024930123,0.0002517602,0.00007945485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005444311,0.00016777229,0.0005733531,0.00020401741,0.000054447402,0.00001996564,0.00016598927,0.00011767257,0.0003793029],"category_scores_gemma":[0.000010479636,0.00012684407,0.0003849316,0.00022538946,0.00006971506,0.000102890845,0.000006481024,0.00027918184,0.000006079471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001553318,0.00037037538,0.0011178693,0.000016341854,0.00017763207,0.000007817108,0.00064318656,0.0001180729,0.96944207,0.000018767743,0.002573453,0.023961069],"study_design_scores_gemma":[0.041665096,0.006740449,0.0062893415,0.0006842599,0.00009953914,0.00013768344,0.0009149573,0.000342983,0.8262132,0.0006034945,0.11584492,0.0004641212],"about_ca_topic_score_codex":0.00002929186,"about_ca_topic_score_gemma":6.697839e-7,"teacher_disagreement_score":0.14322895,"about_ca_system_score_codex":0.00012863363,"about_ca_system_score_gemma":0.00017919163,"threshold_uncertainty_score":0.5172551},"labels":[],"label_agreement":null},{"id":"W2087333240","doi":"10.1097/cji.0b013e31803240fa","title":"Human Papillomavirus 16 E6-specific CD45RA+ CCR7+ High Avidity CD8+ T Cells Fail to Control Tumor Growth Despite Interferon-γ Production in Patients With Cervical Cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Human papillomavirus; Avidity; Medicine; CD8; Cervical cancer; Interferon; Interferon γ; Cancer research; Immunology; Interferon gamma; Cancer; Cytokine; Internal medicine; Immune system; Antigen","score_opus":0.007814464370940874,"score_gpt":0.236006648320105,"score_spread":0.22819218394916413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087333240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869244,0.008745757,0.00071574823,0.00048979046,0.0023359582,0.0007014531,0.000022688737,0.00003355594,0.00003063575],"genre_scores_gemma":[0.9973213,0.0007293194,0.00013505215,0.0009319875,0.00019361642,0.0000225474,0.000010287075,0.00008004826,0.00057585223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967291,0.00053818815,0.0013573198,0.0003992909,0.0002171862,0.00075892435],"domain_scores_gemma":[0.9978688,0.00016212834,0.0008518548,0.00045988784,0.0005957117,0.00006165333],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012562334,0.0004689587,0.0008965406,0.00067899487,0.0002870789,0.00006153519,0.00060689595,0.0002573655,0.000916494],"category_scores_gemma":[0.000035463334,0.00035294972,0.00023515202,0.00047063964,0.00025616537,0.0004386758,0.000037109712,0.00096933806,0.000081826525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041194748,0.0010610126,0.023043238,0.000016852953,0.0006137473,0.000023580555,0.0013676824,0.00003096055,0.91452485,0.000046561177,0.0015223034,0.016554482],"study_design_scores_gemma":[0.01606295,0.004711882,0.46103698,0.00039554175,0.00003744723,0.00006301371,0.00024790104,6.2611136e-8,0.49864298,0.0000644325,0.018254373,0.00048243318],"about_ca_topic_score_codex":0.0004958209,"about_ca_topic_score_gemma":0.00014343324,"teacher_disagreement_score":0.43799374,"about_ca_system_score_codex":0.000614135,"about_ca_system_score_gemma":0.00013815533,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W2111152776","doi":"10.1097/cji.0b013e3181b290f1","title":"Therapeutic (High) Doses of Rituximab Activate Calcium Mobilization and Inhibit B-cell Growth via an Unusual Mechanism Triggered Independently of Both CD20 and Fcγ Receptors","year":2009,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Monoclonal antibody; CD20; Chemistry; Calcium in biology; Rituximab; Intracellular; Cytotoxic T cell; Cell biology; Receptor; Monoclonal; Antibody; Cancer research; Pharmacology; Immunology; Biology; Biochemistry; In vitro","score_opus":0.017812890456479578,"score_gpt":0.2976385071035246,"score_spread":0.279825616647045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111152776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314404,0.0047791055,0.0011602268,0.000481849,0.00009574251,0.00024215424,0.000008252875,0.0000066709445,0.00008194981],"genre_scores_gemma":[0.99071574,0.007848076,0.0008397753,0.00025743892,0.000100897945,0.0000011322903,0.000005807678,0.000023031485,0.00020807376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981895,0.00016626528,0.00068710063,0.00016400329,0.0005789285,0.00021420397],"domain_scores_gemma":[0.9987121,0.00010772654,0.0005448505,0.0001442216,0.00035063518,0.00014047221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055705704,0.00019740185,0.0006535036,0.00034992717,0.00006691478,0.00002196707,0.00012968354,0.0001390447,0.00008117305],"category_scores_gemma":[0.000019880219,0.00014044435,0.00012495922,0.00022160317,0.00013855359,0.00026216754,0.000018590323,0.0003302266,5.4816763e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006018095,0.0010907903,0.0023390413,0.000112183676,0.00019994802,0.00001570301,0.0010791819,0.0000018365504,0.93486214,0.00046247945,0.000019153615,0.053799443],"study_design_scores_gemma":[0.011620501,0.00917119,0.037699446,0.00028701255,0.000089629924,0.00031590887,0.00040433218,0.00012762616,0.93451273,0.005304056,0.00027694594,0.00019062596],"about_ca_topic_score_codex":0.00017598209,"about_ca_topic_score_gemma":0.0000030377735,"teacher_disagreement_score":0.053608816,"about_ca_system_score_codex":0.000039153874,"about_ca_system_score_gemma":0.00012717856,"threshold_uncertainty_score":0.57271546},"labels":[],"label_agreement":null},{"id":"W2151605250","doi":"10.1097/01.cji.0000175685.36239.e5","title":"SSX Cancer Testis Antigens are Expressed in Most Multiple Myeloma Patients","year":2005,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Antigen; Multiple myeloma; Malignancy; Medicine; Cancer; Bone marrow; Synovial sarcoma; Immunohistochemistry; Reverse transcription polymerase chain reaction; Cancer research; Pathology; Internal medicine; Gene; Gene expression; Sarcoma; Immunology; Biology","score_opus":0.011048643253851125,"score_gpt":0.25108637517257176,"score_spread":0.24003773191872063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151605250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939414,0.05838555,0.00007225148,0.0007137766,0.001040161,0.0002267585,0.000047457193,0.000023567482,0.00007647459],"genre_scores_gemma":[0.9853999,0.011758909,0.00029626573,0.0008895553,0.00011396657,0.00001628761,0.000011258387,0.000054018303,0.0014598282],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99779,0.00036087458,0.001025143,0.00020539975,0.00011330893,0.0005052839],"domain_scores_gemma":[0.99808604,0.00032953842,0.00089341064,0.00034221206,0.0003233618,0.00002542261],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043519196,0.00030852552,0.0006349966,0.0004201722,0.00017117047,0.000036182788,0.0005296041,0.00027703703,0.0011376061],"category_scores_gemma":[0.00017266811,0.00025398863,0.00023273686,0.00032445695,0.0001633215,0.00043119557,0.000033509765,0.0006181443,0.00009354984],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033604112,0.0007408652,0.112147294,0.0000072255048,0.0003347832,0.000011192287,0.0014149148,0.00009689069,0.7252071,0.0000039006773,0.002868186,0.15380725],"study_design_scores_gemma":[0.011266896,0.0005098905,0.43892652,0.0003563431,0.000015700505,0.00006460423,0.0002281172,0.0000064440896,0.2871045,0.00001554376,0.26119405,0.0003114324],"about_ca_topic_score_codex":0.00016167463,"about_ca_topic_score_gemma":0.00007528655,"teacher_disagreement_score":0.4381026,"about_ca_system_score_codex":0.00018605441,"about_ca_system_score_gemma":0.00018549846,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W2313266659","doi":"10.1097/cji.0000000000000115","title":"Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance","year":2016,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Trastuzumab; Conjugate; Antibody-drug conjugate; In vivo; Potency; In vitro; Pharmacology; Medicine; Antibody; Cytotoxicity; Cancer research; Monoclonal antibody; Cancer; Immunology; Breast cancer; Biology; Internal medicine; Biochemistry","score_opus":0.014081031302336728,"score_gpt":0.28043528824367997,"score_spread":0.26635425694134324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313266659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775429,0.006892732,0.0036973206,0.010043597,0.00033167232,0.0002251807,0.000023965566,0.000013681425,0.0012289974],"genre_scores_gemma":[0.9671621,0.0056644576,0.0048441994,0.00046871448,0.00017554019,0.0000024127617,0.0000010933392,0.000034253648,0.021647226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980854,0.00009994684,0.00072204735,0.00012808455,0.00068466796,0.00027985807],"domain_scores_gemma":[0.99837714,0.00040604567,0.00044934283,0.00023198173,0.0004038615,0.00013160055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006000653,0.0001681247,0.00058724446,0.00018746333,0.000061480496,0.000012188265,0.00024875242,0.000064863685,0.00067863235],"category_scores_gemma":[0.000117665724,0.00009123656,0.0003420127,0.00013931392,0.00016204927,0.00014522605,0.000023028588,0.0002246181,0.00002162787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068618236,0.00024899928,0.004175596,0.00006896212,0.00041036014,0.00010233504,0.0004056683,4.5758247e-7,0.9633451,0.0015859227,0.0044119796,0.018382797],"study_design_scores_gemma":[0.010503819,0.0013490189,0.037358806,0.0015809953,0.000047809048,0.00036320463,0.000213534,0.0000089634295,0.8334375,0.0068316944,0.10806753,0.0002370985],"about_ca_topic_score_codex":0.000042476247,"about_ca_topic_score_gemma":0.000020212503,"teacher_disagreement_score":0.12990756,"about_ca_system_score_codex":0.00009578324,"about_ca_system_score_gemma":0.00020130773,"threshold_uncertainty_score":0.74305487},"labels":[],"label_agreement":null},{"id":"W2317490780","doi":"10.1097/cji.0b013e3181eccc87","title":"Preclinical Qualification of a New Multi-antigen Candidate Vaccine for Metastatic Melanoma","year":2010,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Learning Partnership; Sanofi (Canada)","funders":"","keywords":"Antigen; Immunogenicity; Immunology; Immune system; Cytotoxic T cell; Antigen presentation; Biology; Melanoma; Ex vivo; Medicine; T cell; Cancer research; Virology; In vitro","score_opus":0.04058313421163846,"score_gpt":0.3532582963415023,"score_spread":0.31267516212986385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317490780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564773,0.024668105,0.015755903,0.0006775847,0.0019221421,0.00043627174,0.000033531618,0.000015626842,0.000013567013],"genre_scores_gemma":[0.9783106,0.004100931,0.014093676,0.00025360327,0.00012390141,0.000014658922,0.00003145538,0.00005783476,0.0030133543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779505,0.00029084377,0.0013989962,0.0001591283,0.000072114846,0.00028387143],"domain_scores_gemma":[0.9970943,0.0006861491,0.0013976974,0.00042606794,0.00036554254,0.000030261474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015553043,0.00021750302,0.0007051848,0.00025539042,0.00011476593,0.000019640256,0.0005201153,0.00021597986,0.00076009973],"category_scores_gemma":[0.00040818265,0.00016404224,0.000463686,0.0001419638,0.000108212844,0.00019833347,0.000016955899,0.00049785076,0.00002517927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076672407,0.0004487291,0.0015928267,0.0000149342795,0.0011803373,0.0000012950072,0.0013272901,0.0000028536501,0.9264497,0.00016090805,0.0016499849,0.059503887],"study_design_scores_gemma":[0.016938882,0.0022009544,0.031310767,0.00009352285,0.00011246369,0.00034159087,0.00026995898,0.00001050023,0.75388426,0.00030733325,0.19427985,0.00024989372],"about_ca_topic_score_codex":0.00013713617,"about_ca_topic_score_gemma":0.000032902433,"teacher_disagreement_score":0.19262987,"about_ca_system_score_codex":0.000019531566,"about_ca_system_score_gemma":0.00041376337,"threshold_uncertainty_score":0.83225596},"labels":[],"label_agreement":null},{"id":"W2324509048","doi":"10.1097/cji.0b013e3182a801f2","title":"Antitumor Impact of Interferon-γ Producing CD1d-restricted NKT Cells in Murine Malignant Mesothelioma","year":2013,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"Mesothelioma Applied Research Foundation","keywords":"CD1D; Mesothelioma; Natural killer T cell; Interferon; Interferon γ; Medicine; Cancer research; Immunology; Interferon gamma; Pathology; Immune system; T cell","score_opus":0.008736423010468595,"score_gpt":0.2684745100164579,"score_spread":0.25973808700598927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324509048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742776,0.0018870677,0.000023213692,0.0002228002,0.00009436194,0.0002460059,0.000009756895,0.0000048925685,0.000084158775],"genre_scores_gemma":[0.9982148,0.00085099274,0.0005232764,0.00009171517,0.00010241947,0.0000036426227,0.0000038235808,0.000020806703,0.0001885436],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881107,0.000040821644,0.00060942624,0.0001013584,0.0002742662,0.00016305463],"domain_scores_gemma":[0.999246,0.000039111703,0.00037089456,0.00017409671,0.000087226756,0.000082649465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012751961,0.00013574892,0.00037269286,0.00029600292,0.000016123107,0.000012441521,0.00011300396,0.000036056736,0.001141954],"category_scores_gemma":[0.000023468529,0.00008723844,0.00023744123,0.00019730385,0.000053425963,0.00019208685,0.000015848203,0.0001423272,0.00002461883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013314192,0.00070452446,0.18678108,0.000034706543,0.00017194642,0.000042122283,0.00016175592,0.00013497424,0.80704504,0.0000015257353,0.00057474244,0.0030161764],"study_design_scores_gemma":[0.0024521085,0.0020236354,0.90362674,0.0004699258,0.000024474119,0.0001374595,0.000056731737,0.00006284307,0.090960726,0.00004130783,0.00006325443,0.0000808232],"about_ca_topic_score_codex":0.00038138966,"about_ca_topic_score_gemma":0.0000013893036,"teacher_disagreement_score":0.71684563,"about_ca_system_score_codex":0.00015850394,"about_ca_system_score_gemma":0.00010682147,"threshold_uncertainty_score":0.9997711},"labels":[],"label_agreement":null},{"id":"W2328883326","doi":"10.1097/cji.0b013e3181fe535b","title":"Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade","year":2010,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Gustave-Roussy; Institut National Du Cancer","keywords":"CD80; Dendritic cell; CD86; CD8; Microvesicles; T cell; Immune system; Immunotherapy; Immunology; Cancer research; Medicine; Chemistry; CD40; In vitro; Cytotoxic T cell; microRNA; Biochemistry","score_opus":0.010022400704014693,"score_gpt":0.31838417230397276,"score_spread":0.3083617715999581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328883326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912063,0.0064460537,0.00048113213,0.0007095495,0.0008874466,0.00019956112,0.000008810303,0.000010503972,0.000050656523],"genre_scores_gemma":[0.9875242,0.001021063,0.010557069,0.00025525145,0.00035242867,0.0000053372,0.000008963899,0.000045955,0.00022969379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803233,0.00012018748,0.0011055296,0.00025904956,0.00022257236,0.00026031118],"domain_scores_gemma":[0.9980519,0.000028714103,0.0006749583,0.0007438048,0.00037418256,0.00012644271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000683815,0.00019079838,0.00042685028,0.00018844882,0.00004856659,0.000017760007,0.00078360114,0.0003134598,0.00006702957],"category_scores_gemma":[0.0002777687,0.00016813313,0.0003468697,0.0002271794,0.00023232495,0.000009985915,0.00008873129,0.0004766785,0.000011431083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006241943,0.0005185422,0.0044458006,0.000010838249,0.00020819475,0.000021898146,0.00003770389,0.000013880035,0.9869417,0.00002845531,0.00095047505,0.006198335],"study_design_scores_gemma":[0.0020091913,0.0010134875,0.005794156,0.000025257417,0.00003539655,0.00014442811,0.000065223285,0.0000033340975,0.9667817,0.00015310971,0.023795089,0.0001796618],"about_ca_topic_score_codex":0.0000032211353,"about_ca_topic_score_gemma":0.0000030082122,"teacher_disagreement_score":0.022844614,"about_ca_system_score_codex":0.000009390996,"about_ca_system_score_gemma":0.00024070809,"threshold_uncertainty_score":0.68562704},"labels":[],"label_agreement":null},{"id":"W2331816454","doi":"10.1097/cji.0b013e31828eed62","title":"Identification of Synthetic Peptides that Inhibit Lipopolysaccharide (LPS) Binding to Myeloid Differentiation Protein-2 (MD-2)","year":2013,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lipopolysaccharide; TLR4; Peptide; Peptide library; Tumor necrosis factor alpha; Phage display; Chemistry; Peptide sequence; Receptor; Molecular biology; Biology; Biochemistry; Immunology; Gene","score_opus":0.009315536270661534,"score_gpt":0.22712660890450412,"score_spread":0.21781107263384258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331816454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362147,0.0020613347,0.0026093596,0.0006517944,0.00050870044,0.00049204077,0.0000025707268,0.000016737771,0.000036004498],"genre_scores_gemma":[0.99776506,0.00066061254,0.000141491,0.000051000672,0.000041671476,0.00003015499,0.000006932889,0.000024027677,0.001279038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825346,0.00026491212,0.0010028068,0.00013293003,0.00011909107,0.0002268043],"domain_scores_gemma":[0.99801004,0.00012604542,0.0012215801,0.0002778367,0.00034314508,0.0000213706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070827664,0.00016946843,0.00036131064,0.00050561747,0.00012682738,0.000059264275,0.00029887588,0.00015963204,0.00060076086],"category_scores_gemma":[0.00016588153,0.00013677342,0.00019974099,0.00014899565,0.000067660265,0.0005467741,0.00002796956,0.0002335276,0.00040023462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003944273,0.000097659766,0.0004134194,0.000022412722,0.00021090862,5.4467444e-7,0.0010991322,0.000011693374,0.9732476,0.00014098157,0.00038835022,0.023972886],"study_design_scores_gemma":[0.0009012744,0.00032742263,0.008428491,0.00031536963,0.000026380168,0.000056870555,0.00045108108,0.0000045463257,0.9883243,0.00027113289,0.0007558705,0.0001372484],"about_ca_topic_score_codex":0.000051766987,"about_ca_topic_score_gemma":0.0000021372527,"teacher_disagreement_score":0.023835639,"about_ca_system_score_codex":0.00008260193,"about_ca_system_score_gemma":0.0000764218,"threshold_uncertainty_score":0.657791},"labels":[],"label_agreement":null},{"id":"W2468294668","doi":"10.1097/cji.0000000000000131","title":"An Association Between Glatiramer Acetate and Malignant Melanoma","year":2016,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glatiramer acetate; Medicine; Melanoma; Dermatology; Association (psychology); Oncology; Internal medicine; Cancer research; Psychology; Disease","score_opus":0.008823298688931851,"score_gpt":0.24556153186318544,"score_spread":0.23673823317425358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468294668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953621,0.0012505937,0.0027020986,0.00037389586,0.0001326499,0.00004230353,0.000010333216,0.0000025835907,0.00012342543],"genre_scores_gemma":[0.9965366,0.0016350147,0.0007190241,0.00014824234,0.00041793892,9.4080326e-7,0.00000329114,0.000014539016,0.00052442163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932945,0.00008116529,0.00024606124,0.000094481984,0.000120100296,0.00012874472],"domain_scores_gemma":[0.9993583,0.000022439768,0.00032347612,0.00013664557,0.00010136245,0.00005777892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040350508,0.00008496487,0.00015218774,0.000037256803,0.000034996356,0.000021121434,0.00011236794,0.000098665485,0.000027045731],"category_scores_gemma":[0.000029794444,0.00005156242,0.000067447276,0.000023038316,0.000020156745,0.00001229231,0.000011117764,0.00004752147,0.0000035425012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009231204,0.00001708834,0.087374255,0.0000014764793,0.00014045289,0.0000024936166,0.00004814511,1.9742104e-7,0.86126935,0.000018120796,0.00032241057,0.050713696],"study_design_scores_gemma":[0.0027550608,0.002276031,0.2031902,0.000051188912,0.00003416501,0.00006685761,0.000032214666,0.0000012859206,0.7100498,0.00039447538,0.080959216,0.00018950478],"about_ca_topic_score_codex":0.0000030787262,"about_ca_topic_score_gemma":0.0000016159128,"teacher_disagreement_score":0.15121953,"about_ca_system_score_codex":0.000020387384,"about_ca_system_score_gemma":0.000039563798,"threshold_uncertainty_score":0.21026546},"labels":[],"label_agreement":null},{"id":"W2514926023","doi":"10.1097/cji.0000000000000134","title":"Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns","year":2016,"lang":"en","type":"review","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Chimeric antigen receptor; Immunotherapy; Suicide gene; Cancer immunotherapy; Immune system; Cancer; Antigen; Cancer cell; Medicine; Cancer research; Haematopoiesis; Immunology; Genetic enhancement; Biology; Stem cell; Internal medicine; Gene","score_opus":0.04820959936286296,"score_gpt":0.38546702949439904,"score_spread":0.3372574301315361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514926023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018950409,0.992594,0.0035206906,0.0003821006,0.0007802067,0.0022279683,0.00013678666,0.000043902226,0.00012482016],"genre_scores_gemma":[0.00002871885,0.9946616,0.00090402126,0.00021198932,0.0012017034,0.00013093078,0.000004363943,0.00033057368,0.0025260837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966617,0.00014038033,0.0015683959,0.0003810257,0.0006222118,0.0006262479],"domain_scores_gemma":[0.99701595,0.00077719707,0.0008632419,0.00057368184,0.00047859843,0.0002913523],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011582997,0.0006638647,0.003288384,0.00057220715,0.00008341415,0.00015997083,0.000513647,0.00039896453,0.0016831886],"category_scores_gemma":[0.00004717987,0.00043561737,0.00111795,0.00031090385,0.00010995983,0.00019282578,0.000049814495,0.00074885535,0.000009292122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019014593,0.000092829636,0.0000013699419,0.0056739766,0.0023608485,0.000034167704,0.00052711344,0.000009874073,0.063187405,0.000062940824,0.0006635776,0.9254844],"study_design_scores_gemma":[0.0034091715,0.0010374831,0.000005511713,0.028342444,0.0002485414,0.00041579723,0.00006269016,0.0000036685246,0.0027007193,0.000023682353,0.96331877,0.0004315353],"about_ca_topic_score_codex":0.000023636541,"about_ca_topic_score_gemma":0.0000034981053,"teacher_disagreement_score":0.9626552,"about_ca_system_score_codex":0.0006916647,"about_ca_system_score_gemma":0.0013645387,"threshold_uncertainty_score":0.99980956},"labels":[],"label_agreement":null},{"id":"W2620810545","doi":"10.1097/cji.0000000000000153","title":"Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix","year":2017,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"Novo Nordisk Fonden; Faculty of Health and Medical Sciences, University of Western Australia; Lundbeckfonden","keywords":"Antigen; Virology; Adjuvant; Immunology; Biology; Vaccination; Immune system; Cervical cancer; Immunity; Cancer; HPV infection; Vaccine efficacy; Medicine; Genetics","score_opus":0.03189571666955576,"score_gpt":0.36957659373390883,"score_spread":0.33768087706435307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620810545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628613,0.009826098,0.00016209872,0.00852391,0.00075097673,0.00033668804,0.0000054386323,0.000010121776,0.017523358],"genre_scores_gemma":[0.99076587,0.0075208656,0.000057547168,0.0008733275,0.00027203024,0.000002682596,3.0397476e-7,0.000020950905,0.0004863972],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988396,0.000057022,0.0004328688,0.00007244325,0.00042490652,0.00017315589],"domain_scores_gemma":[0.9982253,0.000058518115,0.00054691284,0.0006391909,0.00046228926,0.00006781005],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045755156,0.00010202066,0.00035369562,0.000090219444,0.00027719184,0.000048408856,0.00042960336,0.00006149998,0.001061321],"category_scores_gemma":[0.000087539214,0.00005546137,0.0003431378,0.000099670106,0.00010139493,0.00012813955,0.000050464187,0.00040885017,0.0000063833118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002315363,0.0007015508,0.12772731,0.00011219687,0.00086803635,0.000019714545,0.0004941749,0.000014502598,0.19561785,0.00027304338,0.00088333734,0.6709729],"study_design_scores_gemma":[0.004867672,0.0007696994,0.9295584,0.00011928684,0.000057431713,0.000101351085,0.000039962913,0.00001967585,0.031287562,0.0005557523,0.0325537,0.000069494294],"about_ca_topic_score_codex":0.000060800314,"about_ca_topic_score_gemma":0.000018595552,"teacher_disagreement_score":0.8018311,"about_ca_system_score_codex":0.00008523339,"about_ca_system_score_gemma":0.0002374256,"threshold_uncertainty_score":0.9998518},"labels":[],"label_agreement":null},{"id":"W2769377954","doi":"10.1097/cji.0000000000000192","title":"Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells","year":2017,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Ex vivo; Immunology; Cancer research; Cytotoxic T cell; Immunotherapy; Cord blood; Biology; Immune system; Medicine; In vivo; In vitro","score_opus":0.012711771299303416,"score_gpt":0.2528253423525576,"score_spread":0.24011357105325418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769377954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96167284,0.011317384,0.000072738956,0.00051545055,0.025905743,0.00024118603,0.000030066629,0.000035029487,0.00020954556],"genre_scores_gemma":[0.9744302,0.010465625,0.000067379,0.0015025339,0.00041846963,0.000009310969,0.00004094584,0.00006424831,0.0130012715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797994,0.00026079713,0.000871089,0.0003058799,0.00013877035,0.00044350044],"domain_scores_gemma":[0.99650115,0.00012021364,0.0021310383,0.000761099,0.000435754,0.000050763807],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024638273,0.00039805667,0.0007464595,0.0001858395,0.0006020367,0.00020689725,0.00092953193,0.00036401855,0.0055391667],"category_scores_gemma":[0.000021575439,0.00031916273,0.00051949784,0.000056173205,0.00023780923,0.00096947805,0.000102866026,0.0010359929,0.00018252767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005337162,0.0004632963,0.008105723,0.000016250762,0.0016550946,0.000054859847,0.00024825684,0.000007733087,0.96751034,5.432762e-7,0.008989406,0.007611343],"study_design_scores_gemma":[0.007096605,0.0002455514,0.29321438,0.0003659107,0.00008708595,0.00019538697,0.00011287626,0.000002140177,0.69130605,0.000004298258,0.0070634764,0.00030621144],"about_ca_topic_score_codex":0.00020590112,"about_ca_topic_score_gemma":0.00003635068,"teacher_disagreement_score":0.28510866,"about_ca_system_score_codex":0.0001737018,"about_ca_system_score_gemma":0.00015100265,"threshold_uncertainty_score":0.99992603},"labels":[],"label_agreement":null},{"id":"W2778853333","doi":"10.1097/cji.0000000000000208","title":"Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice","year":2017,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Heterologous; Vaccination; Priming (agriculture); Virology; Virus; Immune system; Biology; Antigen; Adjuvant; Immunology","score_opus":0.024945458897702333,"score_gpt":0.33899210261017587,"score_spread":0.31404664371247354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778853333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913834,0.004535612,0.002699034,0.00061422656,0.00010300059,0.00042998305,0.00001503475,0.000002874452,0.00021684913],"genre_scores_gemma":[0.98941606,0.0049456623,0.0047773533,0.00037909846,0.00019220545,0.00003628654,0.000030378114,0.000037157064,0.00018582043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988173,0.0001680738,0.00043053404,0.00017042962,0.00017351349,0.00024009806],"domain_scores_gemma":[0.99833757,0.00003663104,0.000580674,0.00071768404,0.00027924887,0.00004819997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010980307,0.00014051379,0.00025953318,0.00010330405,0.00020640086,0.00012258241,0.0009177076,0.00013995513,0.000037113994],"category_scores_gemma":[0.00011411391,0.00012733668,0.00015260863,0.000043315915,0.000082511106,0.00002756061,0.00006447423,0.00019860422,0.0000012689686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007939366,0.00026426662,0.0007015628,0.000011879356,0.00014361118,0.0000014298292,0.00012566567,0.0000459804,0.94478005,0.0000060183797,0.00027217207,0.04570799],"study_design_scores_gemma":[0.009463728,0.005234597,0.033105586,0.000052505275,0.00001758677,0.00006791728,0.000050916362,0.0004141641,0.9389462,0.00015211548,0.012226788,0.00026792946],"about_ca_topic_score_codex":0.000053069023,"about_ca_topic_score_gemma":0.00014640209,"teacher_disagreement_score":0.04544006,"about_ca_system_score_codex":0.00008811623,"about_ca_system_score_gemma":0.00020663098,"threshold_uncertainty_score":0.51926386},"labels":[],"label_agreement":null},{"id":"W2788965461","doi":"10.1097/cji.0000000000000216","title":"Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products","year":2018,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"David Geffen School of Medicine, University of California, Los Angeles; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; UCLA AIDS Institute; Center for AIDS Research, University of Washington; Jonsson Comprehensive Cancer Center; Parker Institute for Cancer Immunotherapy","keywords":"Flow cytometry; Ex vivo; T cell; Immunology; T-cell receptor; Transgene; Cell therapy; Cell; Genetically modified mouse; Medicine; Biology; Cancer research; In vivo; Immune system; Biochemistry","score_opus":0.03856796019210099,"score_gpt":0.28483959101902384,"score_spread":0.24627163082692285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788965461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961296,0.0016466933,0.0001267235,0.00054364017,0.0006174862,0.0005290099,0.0000065461777,0.000012687285,0.0003876335],"genre_scores_gemma":[0.9928911,0.004961737,0.0006655428,0.000091782305,0.0006382172,0.000005478075,0.000013074088,0.000045067605,0.000688054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979553,0.00017010228,0.0007429503,0.00018815271,0.000650665,0.00029278328],"domain_scores_gemma":[0.9978325,0.00013275964,0.00053438684,0.00036902798,0.0010512623,0.000080071586],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006403898,0.00021063798,0.00059278414,0.0004955434,0.000045594967,0.00002674761,0.00030554953,0.00012975837,0.002251774],"category_scores_gemma":[0.000108902466,0.00015821797,0.00014930069,0.00061668636,0.00015315431,0.00021737331,0.000025993122,0.00040965775,0.000006857358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023333026,0.00058579864,0.008955608,0.000032764427,0.00016615051,0.000013318103,0.002490983,0.0000012726354,0.9451183,0.000005840983,0.00005567709,0.019241225],"study_design_scores_gemma":[0.01183887,0.005568121,0.27095917,0.00022631677,0.000013853601,0.000017793172,0.0001828958,0.00006044985,0.7092326,0.000021598067,0.0017509455,0.00012735052],"about_ca_topic_score_codex":0.000047377118,"about_ca_topic_score_gemma":0.000008737004,"teacher_disagreement_score":0.26200357,"about_ca_system_score_codex":0.0001247285,"about_ca_system_score_gemma":0.0002930719,"threshold_uncertainty_score":0.9986603},"labels":[],"label_agreement":null},{"id":"W2793304410","doi":"10.1097/cji.0000000000000213","title":"The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Diarrhea; Colitis; Discontinuation; Ipilimumab; Relative risk; Gastroenterology; Incidence (geometry); Ulcerative colitis; Oncology; Immunology; Confidence interval; Immunotherapy; Cancer; Disease","score_opus":0.022225291073107372,"score_gpt":0.2951776078196416,"score_spread":0.2729523167465342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793304410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002913405,0.99372345,0.000013225861,0.00014373798,0.00006596994,0.0030787678,0.000045959023,0.000005103153,0.00001036261],"genre_scores_gemma":[0.00068136235,0.9986345,0.00023297043,0.00014533139,0.00003166779,0.00011240841,0.0000074392024,0.00007010591,0.00008417438],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99450105,0.0010238915,0.0032960514,0.0002993766,0.0005906158,0.00028902633],"domain_scores_gemma":[0.99201924,0.00093165203,0.005751048,0.00074549817,0.00046768333,0.00008489696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032294781,0.00059009885,0.008807501,0.0004929623,0.00012611684,0.000061463325,0.00029408,0.00018397975,0.00006140267],"category_scores_gemma":[0.00019222757,0.00026021138,0.002597887,0.0009789101,0.0003120558,0.00014471197,0.000032463045,0.0005267245,5.5004386e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048086564,0.00032797956,0.00038472534,0.34594113,0.5884115,0.000015573414,0.00035590975,2.266704e-7,0.000005169123,0.000004059655,0.000029729821,0.05971533],"study_design_scores_gemma":[0.009691819,0.005480407,0.0045507993,0.23494673,0.720279,0.00025731526,0.00008708332,7.5455847e-7,0.000024731611,0.00001892042,0.024045337,0.000617132],"about_ca_topic_score_codex":0.00005014584,"about_ca_topic_score_gemma":0.000048238166,"teacher_disagreement_score":0.13186748,"about_ca_system_score_codex":0.00019378406,"about_ca_system_score_gemma":0.00038505276,"threshold_uncertainty_score":0.99998504},"labels":[],"label_agreement":null},{"id":"W2932040100","doi":"10.1097/cji.0000000000000261","title":"UV Light–inactivated HSV-1 Stimulates Natural Killer Cell–induced Killing of Prostate Cancer Cells","year":2019,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Terry Fox Research Institute","funders":"","keywords":"TLR2; Peripheral blood mononuclear cell; Biology; Interleukin 21; Herpes simplex virus; Cancer research; Innate immune system; Immune system; Chemistry; Virology; T cell; Immunology; Virus","score_opus":0.006944799991391451,"score_gpt":0.2395682443848913,"score_spread":0.23262344439349986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932040100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96798503,0.013520457,0.000021465123,0.0002752481,0.017469432,0.00022800705,0.0000014932549,0.000018332803,0.00048054568],"genre_scores_gemma":[0.97744566,0.0027870464,0.00005099433,0.00020822498,0.00005972264,0.000002853566,0.000007648855,0.000035920948,0.019401949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851704,0.00016142387,0.0007919986,0.00016065048,0.00008760343,0.00028126047],"domain_scores_gemma":[0.99817944,0.00012222641,0.001065414,0.00022655627,0.00038856504,0.000017818995],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027204465,0.00022695148,0.00051275664,0.00026774764,0.00008549057,0.000021833384,0.00023707008,0.00020566849,0.0035695378],"category_scores_gemma":[0.000010808433,0.00016974573,0.00028954714,0.00018086817,0.000039592967,0.00034915117,0.00002114307,0.00071666157,0.00020611656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027572766,0.00021170336,0.0014734521,0.00002492335,0.0004797404,0.0000020849427,0.0012044427,0.00020432945,0.9858868,0.000006160169,0.0030785846,0.0046704714],"study_design_scores_gemma":[0.003929559,0.0007612403,0.0016571349,0.00021707387,0.000026238331,0.00004407445,0.00048780855,0.00002861829,0.93346107,0.000009592597,0.059193533,0.0001840474],"about_ca_topic_score_codex":0.00010465802,"about_ca_topic_score_gemma":0.0000011102397,"teacher_disagreement_score":0.05611495,"about_ca_system_score_codex":0.00011522446,"about_ca_system_score_gemma":0.00011253152,"threshold_uncertainty_score":0.99734133},"labels":[],"label_agreement":null},{"id":"W2975999637","doi":"10.1097/cji.0000000000000298","title":"Sarcoid-like Reaction Discovered on EBUS-TBNA of Intrathoracic Lymph Nodes During Immunotherapy for Metastatic Melanoma","year":2019,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Melanoma; Immunotherapy; Lymph node; Biopsy; Endobronchial ultrasound; Radiology; Immune system; Oncology; Pathology; Lung cancer; Immunology; Cancer research","score_opus":0.024296157478950146,"score_gpt":0.3287208180704693,"score_spread":0.3044246605915192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975999637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371177,0.0038642595,0.00035719466,0.00068239454,0.0005100203,0.0006501854,0.00002336653,0.000011512202,0.00018928948],"genre_scores_gemma":[0.99221224,0.004106046,0.0018041759,0.00030522997,0.00022215143,0.000016057278,0.000009415509,0.00007892246,0.0012457821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745953,0.00014868531,0.0010028535,0.00022562277,0.00078642933,0.00037685063],"domain_scores_gemma":[0.997842,0.0003477513,0.0008096323,0.00047328338,0.00043042816,0.0000968674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048685,0.0002659908,0.00094375195,0.0005118514,0.000088039706,0.000051360028,0.00027301596,0.00010881043,0.0002468783],"category_scores_gemma":[0.00007360823,0.00019208863,0.0006213306,0.0003047797,0.000084427214,0.00031697523,0.000015354743,0.00035897506,0.00001944072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015736297,0.00086672744,0.0049695745,0.00022362075,0.00094537955,0.000022205391,0.00044299616,0.00003744994,0.950105,0.00003766916,0.00006178046,0.02655129],"study_design_scores_gemma":[0.019989233,0.004943127,0.092881575,0.0012624097,0.00013724428,0.0007866984,0.00072493404,0.0001572237,0.876584,0.00023059126,0.001973399,0.00032959043],"about_ca_topic_score_codex":0.000041023133,"about_ca_topic_score_gemma":0.0000015155232,"teacher_disagreement_score":0.087912,"about_ca_system_score_codex":0.00025978812,"about_ca_system_score_gemma":0.00027722944,"threshold_uncertainty_score":0.7833147},"labels":[],"label_agreement":null},{"id":"W3035205187","doi":"10.1097/cji.0000000000000324","title":"Laryngeal Tuberculosis in a Patient on Avelumab for Metastatic Nasopharyngeal Carcinoma","year":2020,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Infectious Diseases and Tuberculosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Avelumab; Head and neck cancer; Nivolumab; Dysphagia; Immunotherapy; Oncology; Disease; Tuberculosis; Head and neck squamous-cell carcinoma; Internal medicine; Complication; Cancer; Surgery; Pathology","score_opus":0.020776068736206875,"score_gpt":0.2763666499768896,"score_spread":0.25559058124068273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035205187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990916,0.0025284367,0.00014080213,0.005432606,0.00018781069,0.0004886481,0.000021551064,0.000011129373,0.0002729943],"genre_scores_gemma":[0.9899374,0.00039606314,0.0007186029,0.008636739,0.0002336617,0.000021001037,0.0000059490308,0.000039629675,0.000010906526],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986438,0.00006379656,0.000597066,0.00014650686,0.0003158621,0.00023295655],"domain_scores_gemma":[0.99913204,0.0001328809,0.00024827925,0.00013007125,0.00018442511,0.00017232247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016458053,0.00017428749,0.0005330057,0.00018300615,0.000047439557,0.000021854925,0.000085279375,0.00004760122,0.00019214068],"category_scores_gemma":[0.000097432705,0.0001340947,0.00047299455,0.00020994201,0.00002353324,0.00009810097,0.000008861857,0.0002627724,0.0000095370115],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10114749,0.013826784,0.25228795,0.0018688694,0.0076801316,0.005368919,0.027497359,0.0012121476,0.09459521,0.0012160228,0.02799087,0.46530825],"study_design_scores_gemma":[0.1350576,0.12870535,0.6088629,0.0021348759,0.0022788364,0.0034413708,0.0037906657,0.0075197313,0.06000012,0.0014843076,0.044865713,0.0018585699],"about_ca_topic_score_codex":0.000031581265,"about_ca_topic_score_gemma":0.0000025069212,"teacher_disagreement_score":0.4634497,"about_ca_system_score_codex":0.00015498338,"about_ca_system_score_gemma":0.00016258493,"threshold_uncertainty_score":0.5468223},"labels":[],"label_agreement":null},{"id":"W3036843612","doi":"10.1097/cji.0000000000000325","title":"A Phase I, Dose Escalation, Single Dose Trial of Oral Attenuated Salmonella typhimurium Containing Human IL-2 in Patients With Metastatic Gastrointestinal Cancers","year":2020,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Toxicity; Medicine; Flow cytometry; Adverse effect; Progressive disease; Regimen; Pharmacology; Immunology; Salmonella; Cancer; Internal medicine; Chemotherapy; Biology","score_opus":0.029855969778758852,"score_gpt":0.318312273686907,"score_spread":0.28845630390814814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036843612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989917,0.0002567509,0.0002758064,0.00011459276,0.00002908853,0.00028401465,0.000025327086,0.0000019506365,0.000020752572],"genre_scores_gemma":[0.9989665,0.00003612942,0.0007776239,0.000084502644,0.00005831506,0.0000051777624,0.000043049236,0.000019557348,0.000009143536],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99889094,0.00009523025,0.00042935085,0.0001285052,0.00027160317,0.0001843848],"domain_scores_gemma":[0.99910843,0.000012899638,0.00040217902,0.00010642434,0.0002765162,0.00009352064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017228196,0.00012618137,0.0002743372,0.00007940237,0.000031874657,0.000020577143,0.00013117387,0.00002389601,0.00002668901],"category_scores_gemma":[0.000053496067,0.000097432145,0.00008950634,0.00016316626,0.000064937456,0.000013764201,0.000015550122,0.00012293697,5.139188e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32333365,0.002496848,0.031485118,0.000018979064,0.00057423837,0.00006109143,0.00034811717,0.00035428035,0.63161206,0.0000017700646,0.00018808572,0.009525793],"study_design_scores_gemma":[0.71792185,0.17382415,0.03470191,0.00033446145,0.00010290801,0.000050010825,0.00025017277,0.00011011669,0.07133413,0.00003378968,0.0009711419,0.00036533695],"about_ca_topic_score_codex":0.0001609747,"about_ca_topic_score_gemma":0.00007116497,"teacher_disagreement_score":0.5602779,"about_ca_system_score_codex":0.000084448395,"about_ca_system_score_gemma":0.00024918545,"threshold_uncertainty_score":0.39731675},"labels":[],"label_agreement":null},{"id":"W3064097435","doi":"10.1097/cji.0000000000000337","title":"Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; Queen's University","funders":"","keywords":"Medicine; Immunotherapy; Adverse effect; Cancer; Immune system; Cancer immunotherapy; Oncology; Internal medicine; Immunology","score_opus":0.008550274644871467,"score_gpt":0.25309998093780417,"score_spread":0.2445497062929327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3064097435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96677524,0.029851899,0.000091126094,0.001985494,0.00036618326,0.00076436123,0.000024778903,0.000018800343,0.00012211094],"genre_scores_gemma":[0.97153395,0.02610924,0.00085893547,0.0012179184,0.00007134954,0.000022682972,0.000008439516,0.0000922397,0.00008521971],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9966707,0.0001533832,0.0018361673,0.00026794116,0.00070366805,0.0003681266],"domain_scores_gemma":[0.99761903,0.000065944274,0.0013490379,0.00038290353,0.00045882896,0.00012425652],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005096793,0.00037415087,0.0010758791,0.000289956,0.000044375283,0.000004268901,0.00031130793,0.00019729149,0.0011368502],"category_scores_gemma":[0.000027441487,0.00027288377,0.0005194521,0.00068224873,0.00012965806,0.00035452697,0.000021277325,0.00061358267,0.000004499008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37391344,0.0015647132,0.34795287,0.00016145543,0.003239367,0.00006710928,0.00621467,0.00021423875,0.08108434,0.0000054242914,0.00006017406,0.18552221],"study_design_scores_gemma":[0.064064786,0.0064124716,0.9144221,0.002411365,0.00008567073,0.000025081386,0.0003548726,0.000014328766,0.005552984,0.000021773967,0.0062619857,0.00037261212],"about_ca_topic_score_codex":0.00005448133,"about_ca_topic_score_gemma":0.000011229317,"teacher_disagreement_score":0.5664692,"about_ca_system_score_codex":0.0003512115,"about_ca_system_score_gemma":0.00037807724,"threshold_uncertainty_score":0.99997234},"labels":[],"label_agreement":null},{"id":"W3127379102","doi":"10.1097/cji.0000000000000360","title":"Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced Melanoma","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Western University","funders":"","keywords":"Medicine; Prednisone; Hazard ratio; Internal medicine; Confidence interval; Corticosteroid; Oncology; Immunotherapy; Retrospective cohort study; Cancer; Surgery","score_opus":0.00865073645500127,"score_gpt":0.2852234393671364,"score_spread":0.27657270291213515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127379102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932231,0.0056717433,0.00011249897,0.0002673796,0.00022769459,0.00033621938,0.000015866812,0.000009194314,0.00013632444],"genre_scores_gemma":[0.9952123,0.0028995306,0.0010602574,0.0005643133,0.00007417205,0.0000034785628,0.000017637254,0.00006283254,0.00010545406],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99755853,0.00016254358,0.0011518472,0.0002073094,0.0006146357,0.00030514228],"domain_scores_gemma":[0.9976966,0.00019226078,0.00084435235,0.00050881016,0.000669512,0.0000884733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046657122,0.0002966153,0.0008847839,0.00036556198,0.00003541834,0.00002190958,0.00018076305,0.00011160191,0.000659281],"category_scores_gemma":[0.0000697618,0.00019536822,0.0005479665,0.00060328015,0.00009715446,0.00017449592,0.000009950148,0.00039681312,0.0000027464612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13059689,0.0054624146,0.30799365,0.000028778668,0.0018283837,0.00013961505,0.00057542237,0.00017357834,0.23819406,0.0000038576436,0.00016792225,0.31483543],"study_design_scores_gemma":[0.05252791,0.016349075,0.9086862,0.0009565346,0.0000375418,0.00012024439,0.000057478042,0.000007533185,0.01995991,0.0000065212703,0.0010944149,0.00019664784],"about_ca_topic_score_codex":0.0000311699,"about_ca_topic_score_gemma":0.0000056442045,"teacher_disagreement_score":0.6006926,"about_ca_system_score_codex":0.00037469104,"about_ca_system_score_gemma":0.00059229287,"threshold_uncertainty_score":0.7966885},"labels":[],"label_agreement":null},{"id":"W3172587474","doi":"10.1097/cji.0000000000000377","title":"Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Cancer; Immunology; Internal medicine","score_opus":0.012997031282716304,"score_gpt":0.3046834379528645,"score_spread":0.2916864066701482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172587474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601906,0.038515963,0.000016956623,0.0007826231,0.0002523694,0.00018651958,0.000014918057,0.0000051736724,0.000034861212],"genre_scores_gemma":[0.97929263,0.019637525,0.00063064945,0.00022189542,0.000059228532,0.0000021095984,0.0000048167676,0.000027019629,0.00012410618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782586,0.00009048175,0.001455064,0.00015637165,0.0003072056,0.0001650029],"domain_scores_gemma":[0.9984276,0.00018165378,0.000828448,0.00019828044,0.00029482105,0.00006917235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055821764,0.00017070195,0.0008423603,0.00012818539,0.00004412755,0.000018764627,0.00006710963,0.00008239637,0.00007817301],"category_scores_gemma":[0.00012402593,0.0001146761,0.0002324324,0.00021031333,0.00022119784,0.00014019769,0.000030098348,0.00028003682,9.150338e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012285099,0.0005354331,0.87001806,0.000056833098,0.0009186261,0.00002425112,0.00028989682,0.0000018955682,0.0042423722,0.0000029029998,0.000009789066,0.11161481],"study_design_scores_gemma":[0.020635469,0.0012030305,0.9744102,0.0011336526,0.00011619731,0.00003770971,0.00017613453,0.000005884418,0.0012352777,0.00001135941,0.00091265887,0.00012247909],"about_ca_topic_score_codex":0.000174347,"about_ca_topic_score_gemma":0.000027637976,"teacher_disagreement_score":0.111492336,"about_ca_system_score_codex":0.000091444155,"about_ca_system_score_gemma":0.0003091837,"threshold_uncertainty_score":0.46763554},"labels":[],"label_agreement":null},{"id":"W3195519455","doi":"10.1097/cji.0000000000000386","title":"Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Targeting Solutions (Canada)","funders":"","keywords":"Medicine; Cancer research","score_opus":0.019090535158918856,"score_gpt":0.32822564717479075,"score_spread":0.3091351120158719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195519455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9324292,0.040360235,0.007213967,0.0065946924,0.001638344,0.0013501716,0.00005521964,0.000037398804,0.010320792],"genre_scores_gemma":[0.9441322,0.022153527,0.0040691462,0.0052711093,0.001485843,0.000027317137,0.000023514473,0.00017835881,0.022658996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997739,0.00017395646,0.0005727162,0.00024647862,0.00079567207,0.00047215624],"domain_scores_gemma":[0.99651825,0.00019243645,0.0006500471,0.0003124453,0.0021568635,0.00016996653],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006070456,0.00024118269,0.0006007682,0.00025743456,0.00014712471,0.000083184495,0.00023384138,0.00017246137,0.0012287457],"category_scores_gemma":[0.000065230146,0.000204577,0.00067232054,0.00044231972,0.00010811025,0.00013591928,0.000022809176,0.0006670063,0.000009979553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006066801,0.0004281861,0.0002887374,0.00002685453,0.001699186,0.00034852955,0.0013053162,0.00008677077,0.8801858,0.000022429685,0.001231959,0.10830943],"study_design_scores_gemma":[0.015481732,0.0048332857,0.003614572,0.00015638268,0.00031800987,0.0027743252,0.0016614251,0.00020242436,0.9137691,0.00064062525,0.056270853,0.00027721885],"about_ca_topic_score_codex":0.00011736725,"about_ca_topic_score_gemma":0.000012267889,"teacher_disagreement_score":0.10803221,"about_ca_system_score_codex":0.00087692315,"about_ca_system_score_gemma":0.0025385327,"threshold_uncertainty_score":0.9996843},"labels":[],"label_agreement":null},{"id":"W3199751602","doi":"10.1097/cji.0000000000000392","title":"The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Immunotherapy; Hazard ratio; Melanoma; Subgroup analysis; Meta-analysis; Overall survival; Confidence interval; Survival analysis; Biomarker","score_opus":0.009092056313388334,"score_gpt":0.2561128628304968,"score_spread":0.24702080651710845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199751602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145574,0.015028613,0.0005404701,0.0015379932,0.0005990041,0.00067251385,0.000008090399,0.000011684513,0.0001458643],"genre_scores_gemma":[0.98967236,0.0054349652,0.0035898124,0.0008816702,0.00018416664,0.000038410577,0.0000059547124,0.00006175377,0.00013092987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694353,0.00044921407,0.0014165202,0.00020635188,0.0006486508,0.00033573437],"domain_scores_gemma":[0.99681836,0.0006125809,0.0008047251,0.0005062764,0.001139932,0.00011814316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013838412,0.00023457591,0.0005848553,0.00024641253,0.000111719804,0.000052102747,0.00033423034,0.00009706853,0.00011186845],"category_scores_gemma":[0.00072919443,0.00016824498,0.00031558177,0.0006572446,0.00011373336,0.00015251077,0.00003304304,0.00029452232,0.0000062938793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009909369,0.0010765317,0.4756864,0.00009712375,0.0007514942,0.00025548637,0.0010020153,0.0000913069,0.32768467,0.00003423837,0.0006196574,0.18279172],"study_design_scores_gemma":[0.010594676,0.0011992517,0.8733747,0.0012271403,0.00007078628,0.00011612128,0.00028659555,0.00012589175,0.10311298,0.000114522096,0.009529199,0.000248155],"about_ca_topic_score_codex":0.000009996958,"about_ca_topic_score_gemma":0.000008865752,"teacher_disagreement_score":0.3976883,"about_ca_system_score_codex":0.00030121626,"about_ca_system_score_gemma":0.0008600404,"threshold_uncertainty_score":0.6860831},"labels":[],"label_agreement":null},{"id":"W3212489268","doi":"10.1097/cji.0000000000000400","title":"Racial Differences in Survival Among Advanced-stage Non–small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB)","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Quartile; Lung cancer; Comorbidity; Hazard ratio; Proportional hazards model; Confidence interval; Psychological intervention; Cancer; National Death Index","score_opus":0.0169396481623604,"score_gpt":0.3064357109546174,"score_spread":0.28949606279225704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212489268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843419,0.013108447,0.00010175494,0.0003522285,0.001214158,0.00042015145,0.0003088555,0.000007700883,0.0001447758],"genre_scores_gemma":[0.9743367,0.02332762,0.00024038393,0.00081152393,0.00021682555,0.000038258564,0.0000504128,0.0000523996,0.00092589104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639875,0.00038113297,0.001362035,0.00035608816,0.0011273659,0.00037461118],"domain_scores_gemma":[0.99653673,0.00016608722,0.0014607141,0.00051151396,0.0012266329,0.00009831309],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008472723,0.00035111947,0.0011557364,0.0005538556,0.00014708754,0.00005968612,0.0005234892,0.0001658576,0.0013779746],"category_scores_gemma":[0.00006129574,0.0002480264,0.00074086775,0.0017536926,0.00020880507,0.00042128228,0.000045246208,0.00055940624,2.735698e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057589943,0.0010333228,0.8307415,0.00006555997,0.0032830816,0.000016563365,0.0024176475,0.0008199406,0.14500691,0.0000031865534,0.00007667786,0.010776567],"study_design_scores_gemma":[0.0111711575,0.0003835185,0.9624891,0.00074258744,0.00047339345,0.000003142328,0.00046572238,0.0012694682,0.02153752,0.000004844165,0.0011820814,0.0002774133],"about_ca_topic_score_codex":0.0023073312,"about_ca_topic_score_gemma":0.005248353,"teacher_disagreement_score":0.1317476,"about_ca_system_score_codex":0.0006488984,"about_ca_system_score_gemma":0.0014776398,"threshold_uncertainty_score":0.9999972},"labels":[],"label_agreement":null},{"id":"W4205108774","doi":"10.1097/cji.0000000000000409","title":"Rapid Unmasking of Immune-related Adverse Events After Discontinuation of Chemotherapy in Chemo-immunotherapy Regimens","year":2022,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Pembrolizumab; Discontinuation; Adverse effect; Chemotherapy; Incidence (geometry); Cancer","score_opus":0.008424769347801111,"score_gpt":0.25487114318210635,"score_spread":0.24644637383430523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205108774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96971786,0.027556416,0.00010347458,0.0010061057,0.00064329937,0.00065527076,0.000017237304,0.000014167428,0.0002861947],"genre_scores_gemma":[0.9883466,0.009606719,0.00083485944,0.0004959756,0.00006962832,0.000036376594,0.000012676778,0.00009073665,0.0005064763],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953582,0.00032355302,0.002747086,0.00025217124,0.0009487357,0.0003701959],"domain_scores_gemma":[0.99620986,0.0001226505,0.0027248408,0.00059498136,0.00029020422,0.00005747811],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023573954,0.00034607612,0.0011950607,0.000862106,0.00008426298,0.0000060839343,0.00043135835,0.00014850429,0.0028280336],"category_scores_gemma":[0.000032608852,0.0003057618,0.0010524025,0.0010334817,0.00018394722,0.00027964023,0.000043290765,0.00067598996,0.0000013621079],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054520275,0.0022810686,0.024799779,0.000085050284,0.0019815587,0.00006015049,0.00902901,0.0001562848,0.8046117,0.000026144682,0.00013707645,0.10231191],"study_design_scores_gemma":[0.08691979,0.010058473,0.63266546,0.0022497962,0.0002100975,0.00090642564,0.0046088668,0.00018604453,0.23315024,0.0005196174,0.027648464,0.00087673526],"about_ca_topic_score_codex":0.00012291403,"about_ca_topic_score_gemma":0.0000042887045,"teacher_disagreement_score":0.6078657,"about_ca_system_score_codex":0.0005127566,"about_ca_system_score_gemma":0.00041552432,"threshold_uncertainty_score":0.99993944},"labels":[],"label_agreement":null},{"id":"W4220998209","doi":"10.1097/cji.0000000000000418","title":"Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review","year":2022,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Immune system; Programmed cell death; Cytotoxic T cell; Pregnancy; PD-L1; Blocking antibody; Immune tolerance","score_opus":0.023117914531586993,"score_gpt":0.31771295154624396,"score_spread":0.29459503701465695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220998209","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.296916,0.69949955,0.00002626053,0.0023694388,0.00049510377,0.0005417674,0.0000023614882,0.000007682202,0.00014181234],"genre_scores_gemma":[0.6457002,0.35127878,0.0004315598,0.0019219116,0.00025174164,0.000057369703,0.00000309462,0.00004970401,0.0003056105],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99831223,0.00008746487,0.00093596295,0.00009795543,0.0003966583,0.00016972364],"domain_scores_gemma":[0.999077,0.00003272718,0.00054543884,0.00021636901,0.000079604346,0.00004882499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006489745,0.000117443735,0.0005926476,0.00017565236,0.000061709055,0.000010298955,0.00013481038,0.000028068038,0.0013681963],"category_scores_gemma":[0.00004050263,0.00009406768,0.00030777557,0.00030862037,0.000021539428,0.00009608057,0.000032053646,0.00055494957,0.0000021446017],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059176306,0.002475308,0.047737002,0.00995613,0.0008137873,0.0017473561,0.007491153,0.00012636429,0.38319835,0.00004202406,0.0033278756,0.537167],"study_design_scores_gemma":[0.036008365,0.012012606,0.102744155,0.7613493,0.00024263038,0.0050545577,0.0013634659,0.000019032594,0.026435466,0.00020472033,0.05366236,0.00090329297],"about_ca_topic_score_codex":0.00004454946,"about_ca_topic_score_gemma":0.0000058481787,"teacher_disagreement_score":0.7513932,"about_ca_system_score_codex":0.00027956956,"about_ca_system_score_gemma":0.00041598498,"threshold_uncertainty_score":0.9995447},"labels":[],"label_agreement":null},{"id":"W4223419842","doi":"10.1097/cji.0000000000000416","title":"Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience","year":2022,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Food and drug administration; Neurotoxicity; Clinical trial; Lymphoma; Chimeric antigen receptor; Retrospective cohort study; Human immunodeficiency virus (HIV)","score_opus":0.024638429068061577,"score_gpt":0.2989431095813114,"score_spread":0.2743046805132498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223419842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668473,0.0021972202,0.000043370354,0.00039920266,0.0001450341,0.00049006304,0.000026385349,0.000002805441,0.000011182913],"genre_scores_gemma":[0.99652094,0.0013792596,0.0011895748,0.0006426904,0.00002866596,0.000108315966,0.000007904292,0.0000181762,0.00010445155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881595,0.00003537626,0.0005793956,0.00011258365,0.00030549584,0.00015116853],"domain_scores_gemma":[0.9992525,0.00007674221,0.00033922654,0.00015358534,0.00012146505,0.00005645742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020238484,0.00011436548,0.00036028257,0.00016741097,0.000056751862,0.0000092934615,0.000093939,0.000022696659,0.00021075571],"category_scores_gemma":[0.000027559101,0.00008140165,0.00013077441,0.00012813488,0.0000306072,0.00007349366,0.000039789204,0.00008443357,4.1609442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014529558,0.009649853,0.8785626,0.00009027725,0.0005181174,0.000073532814,0.013114813,0.000060782437,0.025627205,0.000022831273,0.0016549788,0.05609542],"study_design_scores_gemma":[0.054435614,0.00937887,0.8824969,0.0003682814,0.00008621132,0.000047787573,0.0027426183,0.00013496917,0.030510629,0.000030395333,0.019587139,0.0001806033],"about_ca_topic_score_codex":0.000054823446,"about_ca_topic_score_gemma":0.0000068262793,"teacher_disagreement_score":0.05591482,"about_ca_system_score_codex":0.0002535983,"about_ca_system_score_gemma":0.00009926875,"threshold_uncertainty_score":0.3319463},"labels":[],"label_agreement":null},{"id":"W4388493259","doi":"10.1097/cji.0000000000000492","title":"Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; CancerCare Manitoba; Manitoba Health; University of Manitoba","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Retrospective cohort study; Odds ratio; Adverse effect; Proportional hazards model; Cancer; Cohort; Logistic regression; Confidence interval; Oncology; Surgery","score_opus":0.006176008549061644,"score_gpt":0.2705369440056471,"score_spread":0.26436093545658546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388493259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906409,0.0073217615,0.000009454344,0.00019781159,0.00030441422,0.0014680385,0.000017754062,0.000017775668,0.000022112254],"genre_scores_gemma":[0.99511373,0.004650599,0.000023289635,0.000024260227,0.000043602195,0.000047457626,0.0000050953317,0.000043790864,0.000048149093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770427,0.00018265874,0.0010316862,0.00021702998,0.0006294435,0.00023492619],"domain_scores_gemma":[0.9984333,0.0001057303,0.0007241758,0.00026852172,0.00039667368,0.00007162581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016452168,0.00023012675,0.00089638255,0.00044945485,0.00006279776,0.000016060156,0.000121221456,0.000063509826,0.00007042757],"category_scores_gemma":[0.00005772162,0.0001594636,0.0002098741,0.00092730706,0.00016131856,0.00016682236,0.000028860415,0.00031679706,6.6252534e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04742861,0.0011961515,0.90603906,0.000107034706,0.0013160873,0.000051000356,0.0011243157,0.000021368536,0.03330505,0.0000016636899,0.000013577982,0.009396069],"study_design_scores_gemma":[0.024141215,0.0035001044,0.96691287,0.0017887272,0.00011784736,0.000009907437,0.00030237666,0.0000086487025,0.0029199596,0.000018007366,0.00011812308,0.00016220524],"about_ca_topic_score_codex":0.00048344114,"about_ca_topic_score_gemma":0.000021071532,"teacher_disagreement_score":0.060873806,"about_ca_system_score_codex":0.0004938607,"about_ca_system_score_gemma":0.000281616,"threshold_uncertainty_score":0.6502737},"labels":[],"label_agreement":null},{"id":"W4390947852","doi":"10.1097/cji.0000000000000501","title":"Nivolumab in Squamous Cell Carcinomas of the Head and Neck (SCCHN): A Real-world Outcome Study in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Contraindication; Hazard ratio; Head and neck; Oncology; Proportional hazards model; Surgical oncology; Cancer; Surgery; Immunotherapy; Confidence interval; Pathology","score_opus":0.023676190117465627,"score_gpt":0.2972688873823677,"score_spread":0.27359269726490204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390947852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866517,0.010067006,3.2809731e-7,0.0012880836,0.00045182556,0.00029254804,0.0000018075033,0.0000028805212,0.0012438239],"genre_scores_gemma":[0.997293,0.00034769025,0.000029694114,0.00026317866,0.000042450858,0.00000414302,1.1710925e-7,0.000016854312,0.002002878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862504,0.00006450405,0.0007045275,0.000112013055,0.00031734697,0.00017658985],"domain_scores_gemma":[0.9994896,0.000096193915,0.00014007174,0.00017678556,0.000055811994,0.000041541683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037065338,0.00012852244,0.0005767491,0.00020784047,0.00003006225,0.000012047535,0.0001089391,0.000028816577,0.00005618484],"category_scores_gemma":[0.000013737029,0.000079232566,0.00008678591,0.00031751095,0.000035199122,0.00005221736,0.000024122763,0.00053571776,1.969237e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052057725,0.00025837668,0.9881868,0.000064469365,0.000060633174,0.00035153225,0.0069621517,0.0000064249352,0.0013414377,0.000003918674,0.000752746,0.0014909833],"study_design_scores_gemma":[0.005067639,0.0011302005,0.9866688,0.00043022813,0.000028434924,0.000049752638,0.0011256386,0.000008760686,0.00032669338,0.000012474874,0.0050799185,0.00007145072],"about_ca_topic_score_codex":0.9576367,"about_ca_topic_score_gemma":0.9975045,"teacher_disagreement_score":0.039867762,"about_ca_system_score_codex":0.0009243106,"about_ca_system_score_gemma":0.0016146643,"threshold_uncertainty_score":0.32310104},"labels":[],"label_agreement":null},{"id":"W4398145149","doi":"10.1097/cji.0000000000000527","title":"False-positive Findings of Large Vessel Vasculitis on FDG-PET in Patients Treated With Immune Checkpoint Inhibitors","year":2024,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Discontinuation; Vasculitis; Positron emission tomography; Radiology; Retrospective cohort study; Immunosuppression; Internal medicine; Nuclear medicine","score_opus":0.005921378093618918,"score_gpt":0.251044565208188,"score_spread":0.2451231871145691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398145149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916877,0.0067437277,0.000022988608,0.00053571834,0.00032192492,0.00033623347,0.00004209109,0.000018239001,0.0002913772],"genre_scores_gemma":[0.9972876,0.0019629647,0.00013251248,0.0002475745,0.000091678085,0.0000049382706,0.000024245825,0.000056136047,0.00019237117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979472,0.000084171515,0.0009874984,0.00018780495,0.0005251282,0.00026816863],"domain_scores_gemma":[0.99907565,0.00009739829,0.00033264523,0.00022040127,0.00021439123,0.000059530266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006788137,0.0002492765,0.00064155355,0.0005568332,0.000037192207,0.000036159585,0.00013148034,0.0000916965,0.00019255956],"category_scores_gemma":[0.000020851303,0.00016701693,0.00034739298,0.0005753266,0.00009266437,0.00019208527,0.000010169342,0.0004433667,0.000006873124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11257155,0.0064668464,0.18016408,0.0006513694,0.008746666,0.0016321908,0.008051095,0.000022261951,0.5924046,0.00022923954,0.0031560147,0.08590405],"study_design_scores_gemma":[0.027722122,0.0113672195,0.6951792,0.0080916565,0.00014535997,0.00031307503,0.00033823226,0.000018190938,0.24821633,0.000029320447,0.008248102,0.00033115342],"about_ca_topic_score_codex":0.00016553672,"about_ca_topic_score_gemma":0.000006118062,"teacher_disagreement_score":0.5150151,"about_ca_system_score_codex":0.00034891852,"about_ca_system_score_gemma":0.00019182186,"threshold_uncertainty_score":0.6810753},"labels":[],"label_agreement":null},{"id":"W4407778016","doi":"10.1097/cji.0000000000000551","title":"The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study","year":2025,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; COPD; Internal medicine; Contraindication; Hazard ratio; Lung cancer; Population; Proportional hazards model; Odds ratio; Oncology; Confidence interval; Pathology","score_opus":0.007702180697183973,"score_gpt":0.32121194922370455,"score_spread":0.31350976852652057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407778016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94016373,0.057130404,0.00004672821,0.00048485314,0.0005251196,0.0016006499,0.000008515861,0.000006289502,0.000033718563],"genre_scores_gemma":[0.99319166,0.0064359526,0.000014099071,0.000066056185,0.00013680354,0.00005424025,0.0000033792003,0.000028489585,0.00006933406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771166,0.00038407271,0.0011169595,0.00018710499,0.00031157373,0.0002886251],"domain_scores_gemma":[0.9981596,0.00024582222,0.0009579004,0.00037078926,0.00019133516,0.00007458527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014619308,0.00024891898,0.0007062346,0.00037647647,0.00014241014,0.000026234196,0.0002134929,0.000055314413,0.000020908017],"category_scores_gemma":[0.000028104596,0.000153363,0.00055694336,0.0005798353,0.00006902469,0.00010054585,0.000019465975,0.00044119533,2.3875094e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07925184,0.0034172034,0.65668607,0.000511311,0.0014548665,0.00006170313,0.0012829045,0.0012800494,0.13791555,0.000004375744,0.000051599756,0.11808254],"study_design_scores_gemma":[0.009991894,0.003467668,0.9771944,0.0026657437,0.000060282546,0.000013013501,0.00040943726,0.00033231862,0.005667448,0.000048267768,0.000034579636,0.00011494329],"about_ca_topic_score_codex":0.0041564987,"about_ca_topic_score_gemma":0.00009370912,"teacher_disagreement_score":0.32050836,"about_ca_system_score_codex":0.0029241752,"about_ca_system_score_gemma":0.0015118239,"threshold_uncertainty_score":0.7646616},"labels":[],"label_agreement":null}]}